Congress of the International Society on Thrombosis and Haemostasis

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

G
Gabazza E.C.	-	REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR
	-	PHOSPHOINOSITIDE 3-KINASE-INDUCED CYTOSKELETAL TRANSLOCATION OF PROTEIN KINASE CK2 IN THROMBIN-STIMULATED PLATELETS
	-	REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
	-	LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
Gabbai A.A.	-	ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Gabbeta J.	-	LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
Gaber K.R.	-	THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ?
Gabi K.	-	EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Gachet C.	-	IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
	-	THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
	-	EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
	-	THE GPIB-V-IX COMPLEX FACILITATES PLATELET PROCOAGULANT ACTIVITY INDEPENDENTLY OF THE GPIB ALPHA NH2 TERMINAL DOMAIN
	-	MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES
	-	VASCULAR WALL ALTERATIONS AND MATRIX EXPOSURE FOLLOWING LASER-INDUCED INJURY OF MOUSE MESENTERIC ARTERIOLES
	-	ABNORMAL MEGAKARYOCYTE MATURATION WITH IMPAIRED PROPLATELET FORMATION IN A MOUSE MODEL OF BERNARD-SOULIER SYNDROME
	-	A MONOCLONAL ANTIBODY AGAINST PLATELET GPIBBETA INHIBITS GPIB-V-IX-DEPENDENT SIGNALLING, PROCOAGULANT ACTIVITY AND THROMBUS FORMATION UNDER FLOW PERFUSION
	-	REDUCED ATHEROSCLEROTIC LESIONS IN P2Y1/APOE DOUBLE KNOCKOUT MICE
	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Gadelha T.	-	807C/T POLYMORPHISM IN THE PLATELET GLYCOPROTEIN IA GENE IN PATIENTS WITH RETINAL VEIN OCCLUSION
	-	FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION
Gadelha T.T.G.	-	ACQUIRED FACTOR XIII INHIBITOR: A CASE REPORT
Gadisseur A.P.	-	INCREASED PLATELET AGGREGATION AFTER DDAVP ADMINISTRATION MAY BE EXPLAINED BY DECREASED EXPRESSION OF THE TETRASPANIN CD9
	-	THE AUTOMATED ENDOGENOUS THROMBIN POTENTIAL (ETP) TEST TO REFLECT COAGULATION CHANGES IN PATIENTS WITH CIRRHOSIS OF THE LIVER
Gaertner R.	-	NOX4 IS STRONGLY INVOLVED IN ENDOTHELIAL PAI-1 SYNTHESIS
Gage B.F.	-	COMPARISON OF THE 30-DAY INCIDENCE OF ISCHEMIC STROKE AND BLEEDING AFTER MAJOR SURGERY IN PATIENTS WITH AND WITHOUT ATRIAL FIBRILLATION (AF)
	-	EFFECT OF SURGICAL PROCEDURES AND SPECIFIED RISK FACTORS ON THE INCIDENCE OF PERI-OPERATIVE STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF)
Gagliano F.	-	HOME CLINICAL ASSISTANCE: SICILIAN SURVEY ON THE HCA SUPPORT FOR THE MANAGEMENT OF THE PROPHYLAXIS IN PAEDIATRIC HAEMOPHILIAC PATIENTS
	-	IMMUNOGLOBULINE ANTI-D (WINRHO) IN CRHONIC CHILDOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), ANALYSIS OF "IMMATURE PLATELET FRACTION (I.P.F.)" AND ASYMPTOMATIC THROMBOCYTOPENIA
Gagnon D.	-	SF-12 PHYSICAL COMPONENT SCORE IS AN INDEPENDENT PREDICTOR OF MAJOR HEMORRHAGE IN A COHORT OF ELDERLY PATIENTS ANTICOAGULATED FOR ATRIAL FIBRILLATION
Gagua R.R.G.	-	APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER
Gahl W.A.	-	PLATELET POLYPHOSPHATE MODULATES PLATELET COAGULATION PROTEIN RESPONSES
Gähler A.	-	EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
Gailani D.	-	REDUCED MORTALITY OF PERITONEAL SEPSIS IN FACTOR XI DEFICIENT MICE
Gaillandre A.	-	EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
Gaillard F.	-	EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
	-	ANTITHROMBOTIC ACTIVITY OF THE TP-RECEPTOR ANTAGONIST TERUTROBAN ON FOLTS-LIKE AND FECL3 INDUCED RAT MODELS OF THROMBOSIS
Gainor J.F.	-	THROMBIN-INITIATED PLATELET ACTIVATION IN VIVO IS VON WILLEBRAND FACTOR INDEPENDENT DURING THROMBUS FORMATION IN A LASER INJURY MODEL
Gajardo R.	-	CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS
	-	NANOFILTRATION APPLIED TO FACTOR IX PURIFICATION PROCESS EFFECTIVELY ELIMINATES AN EXPERIMENTAL TSE-MODEL AGENT
	-	HEPARIN AFFINITY CHROMATOGRAPHY AND ADDITIONAL PURIFICATION STEPS EFFECTIVELY ELIMINATE AN EXPERIMENTAL TSE-MODEL AGENT SPIKED INTO FACTOR VIII/VWF PRODUCTION PROCESS
Gajek H.	-	ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) EXPERIENCE ASSESSED THROUGH ONGOING POST-AUTHORIZATION SAFETY SURVEILLANCE (PASS)
	-	THE USE OF FEIBA DURING SURGERIES IN HAEMOPHILIA PATIENTS WITH INHIBITORS TO FACTOR VIII AND IX
Gala J.	-	DETERMINATION OF VKORC1 AND CYP2C9 GENOTYPES IS OF LIMITED VALUE DURING CHRONIC ANTICOAGULATION WITH ACENOCOUMAROL
Galan A.M.	-	SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
	-	SEROTONIN ENHANCES THE PROCOAGULANT PROPERTIES AND PLATELET ACTIVATION INDUCED DURING PLATELET UP TAKE OF TISSUE FACTOR
Galanakis D.K.	-	DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
	-	PRONOUNCED B KNOB CAPACITY TO MODULATE FIBRIN ARCHITECTURE, STIFFNESS, AND PLASMIN LYSIS
Galanaud J.	-	SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Galbiati V.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
Gale A.J.	-	MECHANISMS OF INACTIVATION OF COAGULATION FACTOR VIIIA BY ACTIVATED PROTEIN C WITH PROTEIN S
	-	ACTIVATED PROTEIN C
	-	RESIDUES 311-325 ON THE HEAVY CHAIN OF FVA REPRESENT AN ACTIVATED PROTEIN C BINDING REGION
Galea V.	-	HEPARIN INDUCED THROMBOCYTOPENIA: A LIFE THREATENING SYNDROME. THREE YEARS OF EXPERIENCE IN A LARGE GENERAL HOSPITAL
Galieni P.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Galieva L.	-	INTERRELATION BETWEEN GENETIC POLYMORPHISM OF HEMOSTATIC SYSTEM AND CORONARY HEART DISEASE IN PATIENTS WITH OBESITY UNDERWENT CORONARY ARTERY BYPASS GRAFTING
Galipeau J.	-	THE IMPORTANCE OF THE PROPEPTIDE FOR CARBOXYLATION OF THE VITAMIN K DEPENDENT CLOTTING FACTORS: STUDIES WITH FACTOR IX
	-	SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
Galland P.	-	MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS
Galli M.	-	INHERITED THROMBOPHILIC ABNORMALITIES AND RISK OF PORTAL VEIN THROMBOSIS: A META-ANALYSIS
	-	PROGNOSTIC SIGNIFICANCE FOR VENOUS THROMBOEMBOLISM (VTE) OF HEMOSTATIC MARKERS IN PATIENTS WITH MULTIPLE MYELOMA (MM) RECEIVING THALIDOMIDE
Gallimore M.J.	-	WHOLE BLOOD AND PLASMA THROMBIN GENERATION ASSAYS IN PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
	-	HUMAN VASCULAR ENDOTHELIAL CELLS INFLUENCE THE WHOLE BLOOD THROMBIN GENERATION ASSAY
Gallinaro L.	-	A NEW (I1372S) MUTATION IN THE A1 DOMAIN OF VON WILLEBRAND FACTOR ASSOCIATED WITH A TYPE 2B-LIKE VON WILLEBRAND DISEASE PHENOTYPE
	-	A TYPE VICENZA-LIKE VON WILLEBRAND DISEASE NOT ASSOCIATED WITH VWF GENE MUTATION NOR ANTI-VWF ANTIBODIES
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
	-	HOW ABO BLOOD GROUPS AFFECT VON WILLEBRAND FACTOR LEVELS IN NORMAL SUBJECTS
Gallus A.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
	-	EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY
Gallus A.S.	-	LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
Galsanamzhilova H.N.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Galstyan G.M.	-	AIRWAY OBSTRUCTION CAUSED BY HEMORRHAGE IN PATIENTS (PTS) WITH INHIBITOR HEMOPHILIA
Galuszka J.	-	AGGREGATION TEST FOR DETECTION CLOPIDOGREL RESISTANCE
Galy-Fauroux I.	-	EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
Gamba G.	-	EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
Gamba A.	-	THROMBOTIC MARKERS AND MITRAL VALVE PROLAPSE IN MIGRAINE WITH AND WITHOUT AURA AT CHILDHOOD ONSET
Gamba G.	-	THROMBOTIC MARKERS AND MITRAL VALVE PROLAPSE IN MIGRAINE WITH AND WITHOUT AURA AT CHILDHOOD ONSET
	-	EFFICACY AND SAFETY OF HIGH DOSES OF FEIBA FOR MAJOR SURGERY IN A PATIENT WITH HAEMOPHILIA A AND HIGH-TITRE INHIBITOR
	-	CARDIOVASCULAR DISEASE, HYPERHOMOCYSTEINEMIA AND ATHEROTHROMBOTIC RISK FACTORS IN PSORIATIC PATIENTS
Gambaryan S.	-	CROSS-TALK OF VWF/GPIB- AND NO/CGMP-INDUCED SIGNALING IN HUMAN PLATELETS
Gamble D.	-	THROMBELASTOGRAPHY STUDY OF HEMOSTATIC AGENTS
Gams E.	-	HAEMATE HS IN PATIENTS WITH SEVERE BLEEDING UNDERGOING VALVE REPLACEMENT DUE TO AORTIC STENOSIS (HAVAS-STUDY)
Gan T.E.	-	A POTENTIAL SOURCE OF ERRONEOUS RESULTS ON AUTOMATED COAGULATION ANALYSERS - AN OBSERVATIONAL STUDY
Ganapathy P.	-	POLYMORPHISMS IN THE IL6 GENE IN FAMILIES WITH EARLY-ONSET CORONARY ARTERY DISEASE (CAD) -INDIAN ATHEROSCLEROSIS RESEARCH STUDY
	-	APOA1 PROMOTER POLYMORPHISMS AND THEIR ASSOCIATION WITH LIPOPROTEINS IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE (CAD)
	-	FVII ACTIVITY AND R353Q POLYMORPHISM IN ASIAN INDIAN FAMILIES WITH CORONARY ARTERY DISEASE
Gando S.	-	THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Gandon-Laloum S.	-	A NOVEL P.ASP344VAL SUBSTITUTION IN THE FIBRINOGEN GAMMA-CHAIN CAUSES DYSFIBRINOGENEMIA ASSOCIATED WITH THROMBOSIS
Gandrille S.	-	COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC
	-	THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING
	-	ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY
	-	EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS)
	-	GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
	-	AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS
	-	RECOMBINATION IN ENDOTHELIAL CELL PROTEIN C RECEPTOR GENE PROCR. INFERENCE FOR THROMBOPHILIC PATIENTS SCREENING
Gane P.	-	INCREASED ADHESION TO ENDOTHELIAL CELLS OF ERYTHROCYTES FROM PATIENTS WITH POLYCYTHEMIA VERA IS MEDIATED BY LAMININ ALPHA5 CHAIN AND LU/BCAM
Ganesan V.	-	PAEDIATRIC STROKE
Ganev V.	-	FREQUENCIES OF CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5, MDR1 ALLELIC VARIANTS IN PATIENTS WITH DIFFERENT ACENOCOUMAROL DOSE REQUIREMENTS
Gangadharan B.	-	GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS ENCODING PORCINE FACTOR VIII INDUCE PROCOAGULANT ACTIVITY IN HEMOPHILIA A MICE WITH PRE-EXISTING FACTOR VIII IMMUNITY
	-	IDENTIFICATION OF A CLINICALLY RELEVANT GENE THERAPY STRATEGY TO TREAT HEMOPHILIA A USING A HIGH-EXPRESSION FACTOR VIII VECTOR AND GENETICALLY-MODIFIED HEMATOPOIETIC STEM CELLS
Ganguly K.	-	PARTIAL FIBRIN ADHESION AND DIFFUSION SUGGESTED RETEPLASE AS THE THERAPEUTIC CHOICE FOR CATHETER DRIVEN THROMBOLYSIS
Ganser A.	-	AN EX VIVO PERFUSION MODEL TO STUDY THE TREATMENT OF THROMBOTIC MICROANGIOPATHY DURING PIG-TO-HUMAN XENOGENIC KIDNEY TRANSPLANTATION
	-	SUCCESSFUL TREATMENT OF PATIENTS WITH INHIBITORS TO COAGULATION FACTOR VIII AND IX BY TREATING CONCOMITANT HEPATITIS C
Gao D.	-	DIFFERENTIAL EFFECTS OF ANTI-PLATELET DRUGS ON THROMBUS FORMATION AND THROMBUS STABILITY
Gao E.	-	GENETIC ABLATION OF JAM-A IMPAIRS SURVIVAL AFTER MYOCARDIAL INFARCT
Garagiola I.	-	DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS
	-	PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP
Garaigorta U.	-	CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS
Garanito M.P.	-	THROMBOCYTOPENIA: ANALYSIS OF 317 PATIENTS
	-	THROMBOSIS IN PRETERM INFANTS: A REPORT OF FIVE CASES TREATED WITH HIGH DOSE OF TISSUE PLASMINOGEN ACTIVATOR (R-TPA)
Garbiero S.	-	THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY
Garcia J.C.F.	-	ASSOCIATION OF OXIDIZED LDL AND LP(A) LIPOPROTEIN WITH EXTENT OF CORONARY ARTERY DISEASE BY ANGIOGRAPHY
	-	CORONARY ARTERY DISEASE (CAD): LACK OF ASSOCIATION BETWEEN APOB/APOA-I RATIO AND ATHEROMATOSIS EXTENT
	-	SECRETORY PHOSPHOLIPASE A2 AND HIGH-SENSITIVITY C-REACTIVE PROTEIN IN CORONARY ARTERY DISEASE
Garcia D.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
Garcia R.A.	-	DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA
Garcia A.A.	-	GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY
García A.	-	IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3
Garcia A.E.	-	ROLE OF PI-3 KINASE BETA ISOFORM ON ADP-INDUCED PLATELET RESPONSES
Garcia D.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
Garcia J.C.F.	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 4G/5G POLYMORPHISM IN CORONARY ARTERY DISEASE AND ITS ASSOCIATION WITH PLASMA PAI-1 LEVELS
Garcia A.	-	NOVEL PLATELET MEMBRANE RECEPTORS AND SIGNALLING PROTEINS
Garcia E.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Garcia de Frutos P.	-	INK4A/ARF DEFICIENT MICE HAVE A DEFICIENT PLATELET FUNCTION
Garcia-Barberá N.	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
García-Barberá N.	-	INFLUENCE OF JAK2 V617F AND OTHER GENETIC RISK FACTORS IN THROMBOSIS AND HEMORRHAGE IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS [PH(-) MPD]
García-Bueno M.J.	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
Garcia-Erce J.	-	SPANISH CONSENSUS STATEMENT ON PHARMACOLOGIC ALTERNATIVES TO ALLOGENEIC BLOOD TRANSFUSIONS: THE SEVILLE'S DOCUMENT*
Garcia-Estañ J.	-	BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
Garcia-Honrubia A.	-	INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
	-	ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY
Garcia-Lozano R.	-	MILD HAEMOPHILIA A (P. A1824T) ASSOCIATED WITH HEREDITARY COAGULATION FACTOR XII DEFICIENCY AND HETEROZYGOUS PROTHROMBIN 20210G/A MUTATION
García-Malo D.M.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Garcia-Munoz S.	-	INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS
García-Raso A.	-	FIVE PROTHROMBOTIC POLYMORHISMS AND VENOUS THROMBOEMBOLISM
	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
	-	THALIDOMIDE AND THROMBOPROPHYLAXIS: TO WHOM AND WHEN
	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
Garcia-Rodriguez M.	-	CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES
García-Torres A.	-	RISK FACTOR PROFILE ASSOCIATED WITH ICD IN SPANISH POPULATION
	-	THE T ALLELE OF THE FXII 46C/T GENE POLYMORPHISM IS RISK FACTOR FOR ICD IN SPANISH POPULATION
Garcin I.	-	THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Gardiner E.E.	-	CONTROL SHEDDING OF GPIB-IX-V AND GPVI BY ADAM FAMILY METALLOPROTEINASES
	-	PROGRAMMED AUTOLOGOUS CLEAVAGE OF PLATELET RECEPTORS
Gardiner C.	-	PREGNANCY MORBIDITY IS ASSOCIATED WITH LOW PLASMA TISSUE FACTOR PATHWAY INHIBITOR LEVELS, INCREASED THROMBIN GENERATION AND RESISTANCE TO ACTIVATED PROTEIN C
Gardiner E.	-	CHEMOANTICOAGULATION VERSUS CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): RESULTS OF THE INTERIM ANALYSIS OF THE FRAGEM TRIAL
Gardiner E.E.	-	RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI
Gardiner C.	-	ACCEPTABILITY AND EFFICACY OF PATIENT SELF-TESTING IN PATIENTS NEW TO THE ANTICOAGULATION CLINIC
Gardner M.D.	-	EVIDENCE FOR TWO FUNCTIONAL CALCIUM-BINDING SITES ON ADAMTS13
	-	NON-CONSERVED/VARIABLE REGIONS IN THE ADAMTS13 METALLOPROTEINASE DOMAIN ARE DETERMINANTS OF SUBSTRATE SPECIFICITY
Garewal G.	-	INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA
Garghetti E.	-	EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS
Garipidou V.	-	GENETIC ANALYSIS IN HYPOFIBRINOGENEMIA IN ELEVEN FAMILIES
Garner S.F.	-	REGULATION OF THE PLATELET PROCOAGULANT RESPONSE
	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
Garner S.	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
Garner S.F.	-	NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
Garnier P.	-	EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
Garrido J.R.	-	PROPHYLAXIS WITH RECOMBINANT FVIIA
	-	SEVERE FACTOR XI DEFICIENCY IN PREGNANT WOMEN: A PROTOCOL FOR LABOUR MANAGEMENT WITH FACTOR XI CONCENTRATE
	-	PRIMARY PROPHYLAXIS WITH RECOMBINANT FACTOR VIIA IN A PATIENT WITH HAEMOPHILIA A AND INHIBITOR
	-	ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
	-	NEW THERAPEUTIC APPROACH IN ACQUIRED HEMOFILIA
Garry F.	-	A STUDY OF D-DIMER LEVELS IN CANCER PATIENTS DURING ANTINEOPLASTIC TREATMENT
	-	A STUDY OF D-DIMER LEVELS IN CANCER PATIENTS DURING ANTINEOPLASTIC TREATMENT
Garside S.	-	EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
Garteiser P.	-	CRYSTAL STRUCTURE OF THE HPC-4 FAB IN COMPLEX WITH PROTEIN C EPITOPE PEPTIDE
Gartner V.	-	6 MONTHS VERSUS PROLONGED ANTICOAGULATION FOR PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH HIGH FACTOR VIII LEVELS
	-	EMOTIONAL IMPLICATIONS OF GENETIC TESTING AND ASPECTS OF COUNSELLING IN WOMEN PRIOR ORAL CONTRACEPTIVE INTAKE
Garypidou V.	-	THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE
Garzon E.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Gascoigne E.W.	-	CONTINUOUS INFUSION OF A HIGH PURITY FACTOR IX (HPFIX) CONCENTRATE IN SURGERY
	-	CLINICAL EXPERIENCE WITH A FACTOR XI (FXI) CONCENTRATE
Gascon P.	-	CANCER AND VENOUS THROMBOEMBOLISM: ROLE OF GENETIC POLYMORPHISMS IN SELECTINS AND TISSUE FACTOR
Gasparollo A.	-	A NOVEL FLOW CYTOMETRIC METHOD FOR THE DETECTION OF RETICULATED PLATELETS BY AN ANTI-BROMODEOXYURIDINE MONOCLONAL ANTIBODY
Gasparyan L.V.	-	RED LASER RADIATION INCREASES PLATELET RESPONSE TO ADP
Gasto C.	-	SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
Gatt A.	-	COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT)
	-	COMPARISON OF THROMBIN GENERATION WITH MODIFIED THROMBOELASTOMETRY IN HAEMOPHILIA A
	-	THROMBIN GENERATION TO MONITOR INHIBITOR BYPASS AGENTS REQUIRES LOW CONCENTRATIONS OF TISSUE FACTOR (TF)
	-	IN VITRO ASSESSMENT OF ANTICOAGULATION REVERSAL WITH ROTEM THROMBOELASTOMETRY
Gatt A.M.	-	HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
Gatt A.	-	SIGNIFICANT VARIATION IN THROMBIN GENERATION POTENTIAL IN "ADEQUATELY" ANTICOAGULATED PATIENTS
Gattei V.	-	A NOVEL FLOW CYTOMETRIC METHOD FOR THE DETECTION OF RETICULATED PLATELETS BY AN ANTI-BROMODEOXYURIDINE MONOCLONAL ANTIBODY
Gattone M.	-	TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Gaudio C.	-	EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
Gaudric A.	-	ABNORMALITIES IN THE SEROTONIN METABOLISM: A PATHOGENIC HYPOTHESIS FOR CENTRAL RETINAL VEIN OCCLUSION (CRVO)
Gaudry L.	-	EFFECTS ON PLATELET AND LEUCOCYTE FUNCTION BY INTRAVENOUS CHINESE MEDICINE WIDELY USED FOR PATIENTS WITH ISCHAEMIC DISEASE IN CHINA
Gaussem P.	-	BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
	-	THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS
	-	COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC
	-	THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS
	-	P2RY12 RECEPTOR POLYMORPHISMS (SNPS) IN PATIENTS WITH A HISTORY OF MYOCARDIAL INFARCTION
	-	ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY
	-	INFLUENCE OF CYP2C19 AND CYP3A4 GENE POLYMORPHISMS ON CLOPIDOGREL RESPONSIVENESS IN HEALTHY SUBJECTS
Gautier P.	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
	-	IDENTIFICATION OF FACTOR VIII GENE MUTATIONS IN 120 HAEMOPHILIA A PATIENTS: DETECTION OF 26 NOVEL MUTATIONS AND CORRELATION WITH FVIII INHIBITOR DEVELOPMENT
Gavalaki M.	-	DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS
Gavasso S.	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM
	-	MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
	-	INCREASED ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PATIENTS OF FAMILIES WITH INHERITED AT DEFECTS
	-	DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN 31 SUBJECTS BELONGING TO 7 FAMILIES WITH FVII DEFICIENCY
Gavrylyuk S.P.	-	EFFECTS OF 7 KDA STREPTOKINASE FRAGMENT ON THE RABBIT HAEMOSTASIS SYSTEM
Gawaz M.	-	PLATELETS, INFLAMMATION AND ATHEROSCLEROSIS
	-	ASPIRIN-RESISTANCE IN CHILDREN
	-	PLATELETS RECRUIT BONE MARROW-DERIVED PROGENITOR CELLS TO ARTERIAL THROMBI IN VIVO
Gayen-Betal S.	-	HEME INDUCES TISSUE FACTOR EXPRESSION IN HUMAN LUNG MICROVASCULAR ENDOTHELIAL CELLS: RELATIONSHIP TO CLINICAL HEMOLYTIC STATES
Gebbink M.F.B.G.	-	THE USE OF TISSUE-TYPE PLASMINOGEN ACTIVATOR TO DETECT MISFOLDED PROTEINS IN BIOPHARMACEUTICALS
Gebbink M.	-	ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
Gebbink M.F.B.G.	-	ACTIVATION OF FACTOR XII BY MISFOLDED PROTEIN AGGREGATES; IMPLICATIONS FOR CONTACT ACTIVATION
	-	ELEVATED PLASMIN-ALPHA2-ANTIPLASMIN LEVELS IN SYSTEMIC AMYLOIDOSIS INDICATE ACTIVATION OF THE FIBRINOLYTIC SYSTEM
Gebhard S.	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
Geer C.B.	-	ANALYSIS OF AFFINITY OF KNOB-HOLE INTERACTIONS RESPONSIBLE FOR FIBRIN POLYMERIZATION
Geerts W.	-	DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
Geerts W.J.C.	-	PLATELET ARCHITECTURE IN THREE DIMENSIONS
Geerts W.H.	-	CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL
Geerts W.	-	INACCURACY OF POINT-OF-CARE (POC) WHOLE BLOOD INR AT INR VALUES GREATER THAN 4
	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
Gehr N.	-	TEST OF ASPIRIN RESISTANCE
Gehrisch S.	-	HIT II-INDUCED CRITICAL LIMB ISCHAEMIA TREATED WITH UROKINASE AND ARGATROBAN
	-	THE ANTICOAGULANT PROTEINS S AND ANTITHROMBIN DISPLAY REMARKABLE SEX-DEPENDENT CHANGES DURING AGING
Geiger M.	-	REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Geipel A.	-	INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
Geisen U.	-	HEMODIALYSER MEMBRANES ALLOW FOR REMOVAL OF ARGATROBAN
Geisen C.	-	SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
Geisen U.	-	HEPARIN-INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
Geisen C.	-	PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
	-	IMPACT OF THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) POLYMORPHISM C.-1639GA UPON PHENPROCOUMON THERAPY
	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
Gelain F.	-	PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA
Geldwerth D.	-	THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A
Gellekink H.	-	SINGLE AND COMBINED EFFECTS OF GENE VARIANTS ON PLASMA TOTAL HOMOCYSTEINE LEVELS: RESULTS OF A CANDIDATE GENE APPROACH IN A POPULATION SAMPLE
	-	CATECHOL-O-METHYLTRANSFERASE GENOTYPE IS ASSOCIATED WITH PLASMA TOTAL HOMOCYSTEINE LEVELS AND MAY INCREASE RECURRENT VENOUS THROMBOSIS RISK
Gelosa P.	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Gemmati D.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Gemmell R.	-	BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
Genc S.	-	ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS
Genc K.	-	ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS
Genevee M.	-	COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT
Geng Y.	-	PROSTACYCLIN IMPROVES TRANSCORONARY MYOCARDIAL DELIVERY OF ADIPOSE TISSUE-DERIVED STROMAL CELLS
Gennarelli M.	-	A CASE OF NORMAL PLATELET COUNT HEPARIN INDUCED THROMBOCYTOPENIA (HIT)
Gensini G.	-	QUALITY OF OAT AND VTE RECURRENCE
	-	ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA
	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
	-	EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
	-	MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
	-	ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION
	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
	-	THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE
	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
Gensini G.F.	-	GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
	-	DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Gensini G.	-	PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE
	-	RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE
	-	LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
Gensini F.	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
Gensini G.	-	PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES
	-	THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS
Gensini G.F.	-	HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES
	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
Gensini G.	-	ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER
Gensini G.F.	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
Gent M.	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
George B.	-	COMBINED FACTOR V AND FACTOR VIII DEFICIENCY IN INDIA - A SERIES OF 31 PATIENTS
	-	MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
Georgescu C.	-	GENOMIC AND STRUCTURAL ANALYSIS OF THE PROTECTIVE EFFECTS OF ACTIVATED PROTEIN C IN A BABOON MODEL OF E. COLI SEPSIS
Georgieva M.D.	-	ROTATION THROMBELASTOGRAPHY APPROACH DURING LIVER TRANSPLANTATION
Georgievska-Ismail L.	-	ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
Gerasimidis T.	-	THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE
Gerdes V.E.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
Gerdes V.E.A.	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
	-	THYROID DISEASES AND THE COAGULATION SYSTEM: A SYSTEMATIC REVIEW
	-	SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY
	-	FAMILY HISTORY, DEEP VENOUS THROMBOSIS AND THROMBOPHILIA
Gerdil C.	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Gergesova E.E.	-	THE CARRIAGE OF FV G1691A, FII G20210A, MTHFR C677T GENES IN PATIENTS WITH ISCHEMIC STROKE IN BURYATS AND RUSSIANS
	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Gerhardt A.	-	FONDAPARINUX IS A SAFE AND EFFECTIVE ALTERNATIVE ANTICOAGULANT IN PREGNANT WOMEN WITH INTOLERANCE TO LOW-MOLECULAR- WEIGHT HEPARINS AND HEPARINOIDS
	-	RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN A SUBSEQUENT PREGNANCY IN WOMEN WITH A FIRST HISTORY OF VENOUS THROMBOSIS
	-	INCREASED PLASMINOGEN ACTIVITY IS AN INDEPENDENT PREDICTOR OF BLEEDING IN HEMOPHILIACS
	-	SUCCESSFUL USE OF RECOMBINANT FACTOR VIIA (RFVIIA, NOVOSEVEN) IN TWO PATIENTS WITH BERNARD SOULIER SYNDROME AND DENTAL EXTRACTION
	-	LONGTERM PROPHYLACTIC TREATMENT WITH FACTOR IX P IN A PATIENT WITH SEVERE CONGENITAL FACTOR X DEFICIENCY
	-	LONGTERM PROPHYLACTIC TREATMENT WITH RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN SEVERE CONGENITAL FACTOR VII DEFICIENT PATIENTS
	-	RISK DETERMINANTS OF ARTERIAL THROMBOSIS INCREASE THE RISK OF INTRAUTERINE GROWTH RESTRICTION (IGR)
	-	INTERACTION BETWEEN ORAL CONTRACEPTIVE USE AND COAGULATION FACTOR LEVELS IN DEEP VEIN THROMBOSIS
	-	RISK STRATIFICATION OF RECURRENT VENOUS THROMBOEMBOLISM
Gerlach H.	-	CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS
Gerlach R.	-	INFLUENCE OF ANTIEPILEPTIC DRUGS ON THE COAGULATION
Gerlach H.	-	DIAGNOSTIC WORK-UP AND DIAGNOSTIC SAFETY IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS DATA FROM THE GERMAN TULIPA REGISTRY
	-	RISK PROFILE OF PATIENTS WITH DVT DIAGNOSED IN AMBULATORY CARE - DATA FROM THE GERMAN TULIPA REGISTRY
Gerlofs-Nijland M.E.	-	THE PROCOAGULANT EFFECTS OF PARTICULATE MATTER, A COMPONENT OF AIR POLUTION, IN THE LUNGS
	-	EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
Gerometta M.	-	EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
	-	SENSITIVITY AND SAFETY OF PULMONARY EMBOLI IMAGING WITH RADIOLABELED ANTI-D-DIMER MONOCLONAL ANTIBODY FRAGMENTS
Gerosa M.	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Gerotziafas G.T.	-	IN VITRO SIMULATION OF BRIDGING THERAPY WITH LMWH AND VITAMIN K ANTAGONISTS. EFFECT ON THROMBIN GENERATION
	-	ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
	-	HYPERCOAGULABLE STATE IN MULTIPLE MYELOMA PATIENTS TREATED OR NOT WITH THALIDOMIDE
	-	INHIBITION OF THROMBIN GENERATION BY IDRAPARINUX AND THE INFLUENCE OF RFVIIA
	-	BRIDGING THERAPY IN PATIENTS TREATED WITH LMWH AND COUMARIN INDUCES DEEP INHIBITION OF THROMBIN GENERATION
Gerotziafas G.	-	THROMBIN GENERATION ASSESSMENT: MONITORING OF ANTICOAGULANT EFFECT OF LMWH TREATMENT AFTER STENTING IN PATIENTS WITH CAROTID ARTERY DISEASE
Gerriets T.	-	INDUCTION OF ENDOTHELIAL CELL HYPERPERMEABILITY BY EXTRACELLULAR RNA
Gerrits J.	-	INSULIN INHIBITS TISSUE FACTOR EXPRESSION IN MONOCYTES
Gershkovich K.B.	-	INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
	-	MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS
Gerss J.	-	CIRCULATING ANGIOPOIETIN-2 IS A STRONG PROGNOSTIC FACTOR IN ACUTE MYELOID LEUKEMIA
Gertow K.	-	ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION
	-	DIFFERENT PATTERN OF TF EXPRESSION IN PLATELETS, LEUKOCYTES AND AGGREGATES OF CAD PATIENTS
Gesheff T.B.	-	LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
	-	EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
	-	DO WE COMPLETELY UNDERSTAND THE ANTITHROMBOTIC EFFECT OF ASPIRIN?
Ghedira I.	-	PLASMA ANGIOGENIC ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOUS
Ghevaert C.	-	RECOMBINANT HUMAN HPA-1A ANTIBODIES FOR TREATMENT OF FETO-MATERNAL ALLO-IMMUNE THROMBOCYTOPENIA (FMAIT): PROOF OF PRINCIPLE IN AN IN VIVO MURINE MODEL
Ghezzi A.	-	INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE
Ghiadoni L.	-	BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
	-	EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM
Ghiotto R.	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
	-	TEN NOVEL MUTATIONS IN FXI GENE
Ghiotto J.	-	THROMBIN ACTIVITY PROFILE: A POWERFUL EX VIVO SCREENING TEST FOR THE DEVELOPMENT OF ANTICOAGULANT DRUGS
Ghirarduzzi A.	-	LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM AFTER DISCONTINUING ANTICOAGULATION IN PATIENTS WITH ACUTE PROXIMAL DEEP VEIN THROMBOSIS OR PULMONARY EMBOLISM. A PROSPECTIVE COHORT STUDY
	-	METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY
	-	D-DIMER TESTING AND RECURRENT VENOUS THROMBOEMBOLISM AFTER UNPROVOKED PULMONARY EMBOLISM
	-	THE RISK OF FATAL PULMONARY EMBOLISM AFTER STOPPING ANTICOAGULANT THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLISM
	-	PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
	-	OUTCOME OF PATIENTS WITH SUSPECTED SYMPTOMATIC DEEP-VEIN THROMBOSIS (DVT) AND A NORMAL ULTRASOUND-BASED INITIAL DIAGNOSTIC WORKUP. A PROSPECTIVE STUDY
Ghosh K.	-	DEEP VENOUS THROMBOSIS IN THE ANTENATAL PERIOD IN A LARGE COHORT OF PREGNANCIES FROM WESTERN INDIA
	-	THROMBOPHILIA AS A CAUSE OF UNEXPLAINED FETAL LOSS IN INDIAN PATIENTS AN IN DEPTH STUDY
	-	CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS
Ghys T.	-	DIAGNOSTIC ACCURACY OF THE TRIAGE D-DIMER TEST FOR EXCLUSION OF VENOUS THROMBOEMBOLISM IN OUTPATIENTS
Giacomelli S.H.	-	ANTITHROMBIN DEFICIENCY IN THE GENERAL POPULATION IS RARELY DUE TO AT GENE MUTATIONS, WHICH ARE MAINLY REPRESENTED BY ALA384SER MUTATION
	-	TEN NOVEL MUTATIONS IN FXI GENE
	-	HETEROGENEITY OF PHENOTYPES IN PATIENTS WITH VON WILLEBRAND DISEASE ASSOCIATED WITH NULL MUTATIONS: AN OBSERVATION IN FAMILIES WITH THREE NOVEL MUTATIONS
Giacomello R.	-	PROTHROMBOTIC FACTORS IN INFANTS WITH NEONATAL CEREBRAL INFARCTION
Giacometti C.	-	RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION
Giambene B.	-	VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS
Gianella A.	-	ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION
Gianluca C.	-	TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION
Giannakopoulos B.	-	BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
Giannarelli C.	-	EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM
	-	BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
	-	BILATERAL THROMBOSIS OF POSTERIOR SHORT CILIORETINAL VESSELS IN A PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, HYPERHOMOCYSTEINE AND ETEROZIGOUS FOR MTHRF
Giannattasio E.R.	-	LMWH BRIDGING FOR ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
Gianni M.	-	INHERITED THROMBOPHILIC ABNORMALITIES AND RISK OF PORTAL VEIN THROMBOSIS: A META-ANALYSIS
	-	BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
	-	SHOULD COMMON INERITED THROMBOPHILIC ABNORMALITIES BE TESTED IN CANCER PATIENT WITH CENTRAL VENOUS CATHETER?
Gianniello F.	-	GYNAECOLOGICAL AND OBSTETRICAL PROBLEMS IN WOMEN AFFECTED WITH INHERITED BLEEDING DISORDERS
Giannini S.	-	A NEW CASE OF ACQUIRED GLANZMANN'S THROMBASTHENIA: COMPARATIVE EVALUATION OF THE DIAGNOSTIC VALUE OF DIFFERENT PLATELET FUNCTION TESTS
	-	LABORATORY DIAGNOSIS AND MONITORING OF DDAVP TREATMENT OF VON WILLEBRAND DISEASE BY FLOW CYTOMETRY
	-	BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV
Giannuzzi P.	-	TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Gianopoulos J.	-	PREGNANCY ASSOCIATED ALTERATIONS OF THE INFLAMMATORY MEDIATORS, TISSUE FACTOR PATHWAY INHIBITOR AND PROTEIN Z
Giansily-Blaizot M.	-	CLINICAL PHENOTYPES AND FACTOR VII GENOTYPE IN CONGENITAL FACTOR VII DEFICIENCY
	-	INHERITED FVII DEFICIENCY MOLECULAR DIAGNOSIS: SCREENING FOR LARGE REARRANGEMENTS IN THE FVII GENE
Gibbins J.M.	-	TACHYKININS AND THE NEUROKININ RECEPTOR 1 ARE REQUIRED FOR PLATELET THROMBUS FORMATION
	-	STRUCTURE-FUNCTION RELATIONSHIPS OF POLYPHENOLS AND THE MODULATION OF PLATELET FUNCTION AND SIGNALLING
Gibbs H.	-	AN ASSESSMENT OF THE EFFECTIVENESS OF INFERIOR VENA CAVA FILTERS IN PREVENTION OF PULMONARY EMBOLISM BASED UPON DEMONSTRATION OF TRAPPED EMBOLUS AT THE TIME OF FILTER RETRIEVAL
	-	CONTRAINDICATIONS TO ANTICOAGULANTS ARE COMMON IN PATIENTS REQUIRING VENOUS THROMBOEMBOLISM PROPHYLAXIS
Gibbs J.	-	CONTRAINDICATIONS TO ANTICOAGULANTS ARE COMMON IN PATIENTS REQUIRING VENOUS THROMBOEMBOLISM PROPHYLAXIS
Gibbs H.	-	AN AUSTRALIAN EXPERIENCE OF RETRIEVABLE INFERIOR VENA CAVA FILTERS IN PATIENTS WITH INCREASED RISK OF THROMBOEMBOLIC DISEASE
	-	DIFFERENTIAL VENOUS THROMBOEMBOLISM PROPHYLAXIS PRESCRIPTION IN PATIENTS WITH SURGICAL AND NON-SURGICAL CONDITIONS ADMITTED TO SURGICAL UNITS
Gibbs J.	-	DIFFERENTIAL VENOUS THROMBOEMBOLISM PROPHYLAXIS PRESCRIPTION IN PATIENTS WITH SURGICAL AND NON-SURGICAL CONDITIONS ADMITTED TO SURGICAL UNITS
Gibbs H.	-	LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
	-	IMPLEMENTATION OF SYSTEM CHANGE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS
Gibbs J.	-	IMPLEMENTATION OF SYSTEM CHANGE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS
Gibbs H.	-	THE IMPLEMENTATION OF A NURSE SPECIALIST MODEL OF CARE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS RATES IN MEDICAL AND SURGICAL PATIENTS
Gibbs J.	-	THE IMPLEMENTATION OF A NURSE SPECIALIST MODEL OF CARE IMPROVES VENOUS THROMBOEMBOLISM PROPHYLAXIS RATES IN MEDICAL AND SURGICAL PATIENTS
Gibson N.S.	-	FURTHER VALIDATION AND SIMPLIFICATION OF THE WELLS CLINICAL DECISION RULE IN PULMONARY EMBOLISM
	-	FAMILY HISTORY, DEEP VENOUS THROMBOSIS AND THROMBOPHILIA
Giese C.	-	EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
	-	DETERMINATION OF THE ANTICOAGULANT ACTIVITY OF IDRAPARINUX IN PATIENTS BY PROTHROMBIN-INDUCED CLOTTING TIME AND HEPTEST
Giglioli C.	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS
Gilabert J.	-	INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
	-	ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION
Gilabert-Estelles J.	-	ANGIOGENESIS IN ENDOMETRIOSIS. INFLUENCE OF THREE FUNCTIONAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) POLYMORPHISMS (-460CT, 405GC AND 936CT) IN VEGF EXPRESSION
	-	INFLUENCE OF PAI-1 4G/5G POLYMORPHISM ON PAI-1 ANTIGEN AND MRNA EXPRESSION IN ENDOMETRIOSIS
Gilbert M.	-	INHIBITION OF PLATELET FUNCTION BY THE ANTI-VON WILLEBRAND FACTOR APTAMER, ARC1779
Gilbert G.E.	-	RELATIONSHIP OF PROCOAGULANT ACTIVITY TO PHOSPHATIDYLSERINE EXPOSURE ON IMMORTALIZED ACUTE PROMYELOCYTIC LEUKEMIA CELLS
Gilbert M.	-	AN ANTI-VON WILLEBRAND'S FACTOR A1 DOMAIN APTAMER INHIBITS ARTERIAL THROMBOSIS INDUCED BY ELECTRICAL INJURY IN CYNOMOLGUS MACAQUES
Gilbert G.E.	-	CRYSTAL STRUCTURE OF THE C2 DOMAIN OF LACTADHERIN
	-	INHIBITOR ANTIBODY LE2E9 AGAINST FACTOR VIII C1 DOMAIN INHIBITS PHOSPHOLIPID BINDING AND ALTERS FACTOR XASE ENZYME COMPLEX FORMATION
Gilbert M.	-	PHARMACOKINETIC PROFILES AND PHARMACOKINETIC AND PHARMACODYNAMIC RELATIONSHIP OF A VWF INHIBITORY APTAMER IN THE CYNOMOLGUS MONKEY
Gilchrist A.	-	EVALUATION OF ALLOSTERIC INHIBITORS OF PAR1 ON PLATELET ACTIVATION
Gilet H.	-	CONVENIENCE OF THE NEW LONG-ACTING ANTICOAGULANT IDRAPARINUX (IDRA) VERSUS VITAMIN K ANTAGONIST (VKA) IN PATIENTS WITH DEEP VENOUS THROMBOSIS (DVT)
Gilio K.	-	FLOW-INDUCED THROMBUS FORMATION ON IMMOBILIZED COLLAGEN RECEPTOR-BINDING PEPTIDES
Gilio J.	-	FREE PROTEIN S LEVELS DURING PREGNANCY
Gilio K.	-	VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
Gill J.C.	-	VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE EFFECTIVELY PREVENTS EXCESSIVE BLEEDING IN PATEINTS WITH VERY LOW VWF:RCO PLASMA LEVELS
	-	THE EFFECT OF ABO BLOOD GROUP ON VON WILLEBRAND FACTOR PROPEPTIDE LEVELS IN NORMAL INDIVIDUALS
	-	ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY
	-	SAFETY AND EFFICACY OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE FOR PROPHYLAXIS DURING ELECTIVE SURGERY IN SUBJECTS WITH VON WILLEBRAND DISEASE
Gillanders K.R.	-	CONTINUOUS INFUSION OF A HIGH PURITY FACTOR IX (HPFIX) CONCENTRATE IN SURGERY
	-	CLINICAL EXPERIENCE WITH A FACTOR XI (FXI) CONCENTRATE
Gilles J.G.	-	A LIMITED NUMBER OF ANTI-IDIOTYPIC ANTIBODIES NEUTRALIZE FVIII INHIBITORS AND RESTORE FULL FVIII ACTIVITY IN THE PLASMA OF HAEMOPHILIA PATIENTS
Gillijns V.	-	DEVELOPMENT OF MEGAKARYOCYTE-SPECIFIC LENTIVIRAL VECTORS FOR GENE THERAPY OF PLATELET DISORDERS
Gilmore G.	-	COMPARISON OF TWO ASSAYS FOR THE MEASUREMENT OF URINARY 11-DEHYRO THROMBOXANE B2
Gils A.	-	BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF AN EXTREMELY STABLE TAFI VARIANT
	-	SIMULTANEOUS INHIBITION OF TAFI AND PAI-1 BY A HETERODIMER DIABODY
	-	THE BIOCHEMICAL IMPORTANCE OF GLYCOSYLATION IN THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR
Gimeno J.	-	ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY
Gin B.	-	FACTOR V LEIDEN (FVL) AND PROTHROMBIN GENE VARIANT (PGV) MAY BE ONLY WEAKLY ASSOCIATED WITH PLACENTA MEDIATED PREGNANCY COMPLICATIONS: A LARGE PROSPECTIVE COHORT STUDY
Gingis-Velitski S.	-	HEPARANASE INDUCES TFPI EXPRESSION AND EXTRACELLULAR ACCUMULATION IN ENDOTHELIAL AND TUMOR CELLS
Ginsberg J.S.	-	A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA)
Ginsberg J.	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
	-	DABIGATRAN ETEXILATE VERSUS ENOXAPARIN IN PREVENTING VENOUS THROMBOEMBOLISM FOLLOWING TOTAL KNEE ARTHROPLASTY
Ginsberg J.S.	-	RECURRENT DEEP VEIN THROMBOSIS (DVT) IS EXCLUDED BY A NEGATIVE D-DIMER OR SERIAL COMPRESSION ULTRASONOGRAPHY (CUS): RESULTS OF A MULTICENTER MANAGEMENT STUDY
Ginsberg J.	-	PERSISTENT VENOUS SYMPTOMS AND SIGNS 1 MONTH AFTER A FIRST DIAGNOSIS OF DVT PREDICT DEVELOPMENT OF THE POST-THROMBOTIC SYNDROME (PTS) DURING 2 YEARS FOLLOW-UP
	-	RISK OF VENOUS THROMBOEMBOLISM (VTE) IN FIRST DEGREE RELATIVES (FDRS) OF PATIENTS WITH UNPROVOKED VTE WHO DO NOT HAVE FACTOR V LEIDEN (FVL) OR THE G20210A PROTHROMBIN GENE MUTATION (PGM)
	-	EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
	-	EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
	-	COMPARISON OF THE INCIDENCE OF RECURRENT VENOUS THROMBOEMBOLISM AFTER PREGNANCY-ASSOCIATED VTE VERSUS IDIOPATHIC VTE
Ginsberg J.S.	-	COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
Ginsburg D.	-	MUTATIONS THAT RENDER VON WILLEBRAND FACTOR (VWF) RESISTANT TO ADAMTS13 CLEAVAGE
	-	AN ENU MUTAGENESIS SCREEN FOR DOMINANT GENETIC MODIFIERS OF THROMBOSIS IN THE FACTOR 5 LEIDEN MOUSE
	-	DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
	-	ABSENCE OF ADAMTS13 ON A VWF DEFICIENT BACKGROUND IS NO LONGER PROTHROMBOTIC IN A MURINE MODEL OF ARTERIAL THROMBOSIS
	-	REGULATION OF PLASMA VON WILLEBRAND FACTOR (VWF) BY MODIFIER GENES
Giordano G.	-	A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY
	-	THROMBOCYTOPENIA AND CONGENITAL RADIAL DYSPLASIA: A CONTINUUM SPECTRUM OF DISEASES. CASE REPORT
Giorgi G.	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
Giougi E.	-	HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES
Girard N.	-	EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
Girard P.	-	MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
Giraudeau B.	-	INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
Girelli D.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Giridhara Rao J.	-	MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
	-	NINE NOVEL MUTATIONS IDENTIFIED IN GLYCOPROTEINS (GP) IB AND IX GENES AMONG 13 UNRELATED PATIENTS WITH BERNARD SOULIER SYNDROME IN INDIA
	-	POLYMORPHISMS IN COAGULANT AND INFLAMMATORY GENES MODIFY THE PHENOTYPE OF SEVERE HEMOPHILIA A AND B
Girisch M.	-	ASPIRIN-RESISTANCE IN CHILDREN
	-	ANTICOAGULATION IN CHILDREN WITH DISTAL SPLENORENAL SHUNT (WARREN SHUNT) OR MESENTERICO- LEFT PORTAL SHUNT (REX SHUNT)
Girma J.	-	EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
Girndt M.	-	COUNTS OF CD14++CD16+ MONOCYTES PREDICT CARDIOVASCULAR EVENTS IN DIALYSIS PATIENTS
Girolami A.	-	MYOCARDIAL INFARCTION AFTER OVARIAN STIMULATION FOR INFERTILITY MANAGEMENT
Girolami B.	-	MYOCARDIAL INFARCTION AFTER OVARIAN STIMULATION FOR INFERTILITY MANAGEMENT
Girolami A.	-	RETINAL CENTRAL ARTERY OCCLUSION AFTER 10 PILLS OF DROSPIRENONE CONTAINING PREPARATION (YASMIN)
Girolami B.	-	RETINAL CENTRAL ARTERY OCCLUSION AFTER 10 PILLS OF DROSPIRENONE CONTAINING PREPARATION (YASMIN)
Girolami A.	-	VENOUS THROMBOSIS DURING ORAL CONTRACEPTION IN NORMAL OR THROMBOPHILIC WOMEN WHO HAD REMAINED ASYMPTOMATIC DURING PAST PREGNANCIES
Girolami B.	-	VENOUS THROMBOSIS DURING ORAL CONTRACEPTION IN NORMAL OR THROMBOPHILIC WOMEN WHO HAD REMAINED ASYMPTOMATIC DURING PAST PREGNANCIES
Girolami A.	-	THREE NEW MUTATIONS IN FXII DEFICIENCY
Gissel M.	-	THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
Gissel M.T.	-	FACTOR XIA (FXIA) AND TISSUE FACTOR (TF) ACTIVITY IN PLASMA OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
Gitter M.L.	-	RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
Giudicelli Y.	-	FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
	-	CUTANEOUS REACTION TO LOW MOLECULAR WEIGHT HEPARIN AND HOMOZYGOUSIS FOR FACTOR V LEIDEN MUTATION DURING PREGNANCY: A CASE REPORT
Giugliano R.P.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Giuliana G.	-	THE NATURAL HISTORY OF D-DIMER LEVELS IN SUBJECTS WITH NEGATIVE D-DIMER AFTER SUSPENSION OF ORAL ANTICOAGULATION FOR A FIRST EPISODE OF VENOUS THROMBOEMBOLISM: THE PROSPECTIVE OBSERVATIONAL PROLONG II STUDY
Giuliani F.	-	TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION
Giusti B.	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
	-	HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM
	-	ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS
	-	GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM
	-	ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS
Gladigau E.L.	-	GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
Glamocanin S.	-	A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT)
	-	HOSPITALISATION FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD- IS IT ALWAYS NECESSARY?
Glatz J.F.C.	-	HEART-TYPE FATTY ACID BINDING PROTEIN IS PREDICTIVE FOR MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
Gleiss A.	-	EFFECTS OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) ON RESTORING THROMBIN GENERATION IN PATIENTS WITH HEMOPHILIA A AND ANTIBODIES TO FACTOR VIII
	-	CISPLATIN INDUCES IN VITRO THROMBIN GENERATION VIA FORMATION OF PROCOAGULANT ENDOTHELIAL MICROPARTICLES
Glembotsky A.C.	-	INVOLVEMENT OF THE TPO/MPL PATHWAY IN THE PATHOGENESIS OF INHERITED THROMBOCYTOPENIAS
Glencross D.K.	-	MONOCYTE PLATELET COMPLEXES: A POTENTIAL FLOW CYTOMETRIC ASSAY FOR SCREENING PRE-THROMBOTIC EVENTS IN HIV POSITIVE PATIENTS
Glenn J.R.	-	RAISED LEVELS OF CD39 IN LEUCOCYTOSIS RESULT IN MARKED INHIBITION OF ADP-INDUCED PLATELET AGGREGATION VIA RAPID ADP HYDROLYSIS
Glibina T.M.	-	MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
Glogar D.	-	CORONARY INSTENT RESTENOSIS OF DRUG-ELUTING STENTS IS ASSOCIATED WITH SERUM LEVELS OF MMP-9
Gmyr V.	-	ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION
Gnida C.	-	D-DIMER LEVELS IN RELATION TO FACTOR V 1691 GENOTYPE AND ORAL ANTICOAGULATION. A CASE-CONTROL-STUDY OF 46 HOMOZYGOUS AND HETEROZYGOUS FACTOR V LEIDEN PATIENTS
	-	D-DIMER LEVELS IN RELATION TO FACTOR V 1691 GENOTYPE AND ORAL ANTICOAGULATION. A CASE-CONTROL-STUDY OF 46 HOMOZYGOUS AND HETEROZYGOUS FACTOR V LEIDEN PATIENTS
Goda T.	-	CLINICAL SIGNIFICANCE OF MEAN PLATELETS VOLUME IN CORONARY ARTERY DISEASE
	-	CLINICAL SIGNIFICANCE OF MEAN PLATELETS VOLUME IN CORONARY ARTERY DISEASE
Godal H.C.	-	FIBRINOGEN AND FIBRIN INDUCE SYNTHESIS OF PROINFLAMMATORY CYTOKINES FROM PERIPHERAL BLOOD MONONUCLEAR CELLS
Goddard N.	-	PRIMARY KNEE ARTHOPLASTY USING RECOMBINANT FACTOR VIIA (RFVIIA) AS FIRST-LINE THERAPY IN HAEMOPHILIA PATIENTS WITH HIGH RESPONDING INHIBITORS
Godino C.	-	PLATELET P-SELECTIN IS ASSOCIATED WITH CIRCULATING NEUTROPHIL ACTIVATION AT THE VERY ONSET OF MYOCARDIAL INFARCTION
	-	EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
Godlewski J.	-	REDUCED CLOT PERMEABILITY AND SUSCEPTIBILITY TO LYSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME: EFFECTS OF INFLAMMATION AND OXIDATIVE STRESS
Goel A.	-	RISTOCETIN-INDUCED AGGREGATION OF HUMAN GPIBALPHA TRANSGENIC MICE IS INHIBITED BY ANTI-HUMAN GPIBALPHA ANTIBODIES IN THE PRESENCE OF HUMAN PLASMA
Goerge T.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Goguen J.D.	-	FIBRIN AND FIBRINOLYSIS IN INFECTION AND HOST DEFENSE
Goizet C.	-	PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A
Gokudan S.	-	Pharmacokinetics of a mixture of FVIIa and FX in rats
Golanski J.	-	P2Y12 ANTAGONIST COMPLEMENTARY TO ASPIRIN THERAPY IS SUPERIOR TO ASPIRIN ALONE IN PATIENTS AFTER CARDIOSURGERY OPERATIONS
Golanski R.	-	P2Y12 ANTAGONIST COMPLEMENTARY TO ASPIRIN THERAPY IS SUPERIOR TO ASPIRIN ALONE IN PATIENTS AFTER CARDIOSURGERY OPERATIONS
Golanski J.A.	-	HOW TO EFFECTIVELY MEASURE THE INHIBITION OF THROMBOXANE GENERATION BY ASPIRIN IN WHOLE CITRATED BLOOD?
Golanski R.	-	HOW TO EFFECTIVELY MEASURE THE INHIBITION OF THROMBOXANE GENERATION BY ASPIRIN IN WHOLE CITRATED BLOOD?
Golanski J.	-	THE METHODOLOGICAL PROBLEMS IN BLOOD PLATELET INVESTIGATION ARE STILL ACTUAL
Gold H.K.	-	MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI)
Goldenberg N.A.	-	A THROMBOLYTIC REGIMEN FOR HIGH-RISK DEEP VENOUS THROMBOSIS MAY SUBSTANTIALLY REDUCE THE RISK OF POST-THROMBOTIC SYNDROME IN CHILDREN
Goldhaber S.Z.	-	LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
	-	RISK STRATIFICATION FOR PULMONARY EMBOLISM
Goldstein G.	-	PERINATAL ISCHEMIC STROKE AND THE INCIDENCE OF MATERNAL AND NEONATAL THROMBOPHILIA
Golmard J.	-	IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
Golovina O.G.	-	HYPERHOMOCYSTEINEMYA IS COMMON IN ACUTE CORONARY SYNDROMES IN NORTH-WESTERN RUSSIA
Golpayegani M.	-	EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
	-	THROMBOSIS IN BETA THALASSEMIA MAJOR
Golshayan D.	-	RISK FACTORS PREDICTIVE OF CARDIOVASCULAR EVENTS IN AN INCIDENT DIALYSIS COHORT: A ROLE FOR HOMOCYSTEINEMIA AND ITS MTHFR GENOTYPE
Golubeva M.G.	-	THYROTROPIN-RELEASING HORMONE CHANGE THE PLATELET-ERYTHROCITE INTERACTION AND OSMOTIC FRAGILITY
	-	NEW VASOPRESSIN ANALOG REMESTYPE INCREASES PLASMINOGEN ACTIVATOR IN RAT BLOOD
	-	INFLUENCE OF NEUROHYPOPHYSIAL C-TERMINAL OLYGOPEPTIDES ON PLATELET AGGREGATION
Golubovich V.P.	-	INFLUENCE OF NEUROHYPOPHYSIAL C-TERMINAL OLYGOPEPTIDES ON PLATELET AGGREGATION
Gomez R.M.	-	ROLE OF PPAR-GAMMA ACTIVATION IN MEGAKARYOCYTOPOIESIS
	-	IMPAIRED THROMBOPOIESIS AFTER STEM CELL INFECTION WITH JUNIN VIRUS
Gómez N.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Gomez R.M.	-	GALECTIN-1 BINDING TO PLATELETS: A NEW MECHANISM FOR PLATELET ACTIVATION
Gomez E.	-	SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK
Gómez N.	-	THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY
Gomez R.M.	-	DIFFERENTIATION OF CD34+ CELLS MEDIATED BY THROMBOPOIETIN AND MONOCYTES/MACROPHAGES
Gómez-Huelgas R.	-	BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
Gómez-Outes A.	-	BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
	-	CLINICAL OUTCOMES DURING BEMIPARIN POST-MARKETING OBSERVATIONAL STUDIES ON PROPHYLAXIS OF VENOUS THROMBOEMBOLISM
Gomperts E.D.	-	HFE GENE MUTATIONS DO NOT SHOW ASSOCIATIONS WITH HEMOPHILIC ARTHROPATHY
	-	ASSOCIATION BETWEEN A HISTORY OF INHIBITORS AND DELAYS IN SKELETAL MATURATION IN ADOLESCENTS WITH HEMOPHILIA
Gonçalves M.	-	ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY
Gonen O.	-	EFFECT OF FIBRIN MATRICES ON INCREASED PROLIFERATION AND SPREADING OF EARLY TERM TROPHOBLASTS AND PLACENTAL VILLI. MODULATION OF COAGULATION AND ANGIOGENESIS FUNCTIONS
Gong X.	-	AN ULTRA SENSITIVE ASSAY FOR THE QUANTIFICATION OF GPVI SHEDDING IN HUMAN PLASMA
	-	FUNCTIONAL ANALYSIS OF ANTI-GPVI MONOCLONAL ANTIBODIES WITH DISTINCT BINDING SITES
	-	MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
Gonzalez A.	-	DEFINITIVE PACEMAKER'S IN ANTICOAGULATED PATIENTS
González M.H.	-	PLATELET FUNCTION (PFA-100) AND ACTIVATION IN PATIENTS WITH CHRONIC PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISORDERS: ROLE OF THE JAK2 V617F MUTATION
González M.	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Gonzalez M.J.	-	ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Gonzalez N.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Gonzalez R.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Gonzalez-Alva C.	-	BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
González-Conejero R.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Gonzalez-Conejero R.	-	INFLUENCE OF FACTOR VII 323 DEL/INS POLYMORPHISM IN THE PROTHROMBOTIC STATE AND ISCHAEMIC STROKE RISK IN ATRIAL FIBRILLATION
	-	ANNEXIN A5 1 C/T POLYMORPHISM DISPLAYS A BETTER OUTCOME IN A LONG TERM FOLLOW-UP AFTER PREMATURE MYOCARDIAL INFARCTION
González-Conejero R.	-	GENETIC INTERACTION OF VKORC1 C1173T/CALUMENIN A29809G MODULATES THE ANTICOAGULANT RESPONSE TO ACENOCOUMAROL
	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Gonzalez-Conejero R.	-	ROLE OF TISSUE REMODELLING IN HYPERTROPHIC MYOCARDIOPATHY
González-Conejero R.	-	BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
	-	HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN
González-Porras J.R.	-	ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Gonzalez-Zarate M.	-	EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
Goodall A.H.	-	DESIGN OF A PLATELET SUBSTITUTE UTILISING HOST FIBRINOGEN TO ENHANCE HAEMOSTASIS
	-	GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
	-	THE SPECTRUM OF THE PLATELET RESPONSE
	-	INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
	-	ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
	-	MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
	-	PAI-1 IN PLATELETS IS DEPENDENT ON THE 4G/5G POLYMORPHISM
	-	REGULATION OF THE PLATELET PROCOAGULANT RESPONSE
	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
	-	CIRCADIAN VARIATION IN THE PLATELET RESPONSE AND THE EFFECT OF MELATONIN
	-	TRANSIENT REVERSAL OF THE ANTI-PLATELET EFFECT OF ASPIRIN AFTER ADMINISTRATION OF UNFRACTIONATED HEPARIN IN HEALTHY SUBJECTS
	-	PLATELETS INDUCE PAI-1 GENE EXPRESSION IN MONOCYTES THROUGH TGF-BETA
	-	ACTIVATED PLATELETS INDUCE TISSUE FACTOR PATHWAY INHIBITOR IN PERIPHERAL BLOOD MONOCYTES
Goodall A.	-	PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Goodall A.H.	-	THE EFFECT OF APHERESIS ON DONORS' PLATELETS
Goodeve A.	-	THE UK NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEME (UK NEQAS) FOR MOLECULAR GENETIC TESTING IN HAEMOPHILIA
Goodeve A.C.	-	THE ISTH SSC VON WILLEBRAND FACTOR (VWF) ONLINE DATABASE
Goodeve A.	-	VICENZA MUTATION R1205H IDENTIFIED IN TWO TYPE 1 VON WILLEBRAND DISEASE FAMILIES FROM ISRAEL
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	TYPE 1 VON WILLEBRAND DISEASE (VWD)
Goodwin C.A.	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC BLOOD BASED APPROACH
	-	MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS HEPARIN SENSITIVE PEAKS IN THE SERUM PEPTIDOME OF NORMAL HEALTHY INDIVIDUALS
	-	MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS PEAKS ARE DIFFERENT IN THE SERUM PEPTIDOME IN COMPARISON TO THE PLASMA PEPTIDOME
	-	AT LOW CONCENTRATIONS OF TISSUE FACTOR, CIRCULATING MICROPARTICLES CAUSE A MARKED SHORTENING OF THE RECALCIFICATION TIMES OF PLASMA FROM NORMAL HEALTHY INDIVIDUALS
Goodwin J.	-	FREQUENCY OF "SPECIAL POPULATION" CHARACTERISTICS IN VENOUS THROMBOEMBOLISM PATIENTS IN CLINICAL PRACTICE: EFFECT ON PATIENT MANAGEMENT
Goodwin C.A.	-	THE DISCRIMINATION OF GENERIC FORMS OF LMW HEPARIN USING A PROTEOMIC CELL-BASED APPROACH
Gorbacheva L.R.	-	ANTI-APOPTOTIC EFFECTS OF SERINE PROTEINASES OF HEMOSTASIS AT GLUTAMATE-INDUCED NEUROTOXICITY
Gorbacheva L.	-	DIRECT PROTECTIVE EFFECT OF ACTIVATED PROTEIN C ON MAST CELLS DEGRANULATION
Gordon M.V.	-	HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
Gorgy G.	-	TRITON X-100 IS RESPONSIBLE FOR THE LOSS OF ALPHA2-ANTIPLASMIN INHIBITORY ACTIVITY IN SOLVENT-DETERGENT TREATED PLASMA
Gori A.	-	CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY
	-	LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
	-	CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY
	-	LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
	-	ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS
	-	PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION
	-	CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY
	-	PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS
Gori A.M.	-	DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
	-	IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS
Gori A.	-	HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY
Gori A.M.	-	ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY
	-	HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
	-	ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS
Gori A.	-	MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
	-	POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI
	-	B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
Gorina E.	-	INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA A TREATED WITH SUCROSE-FORMULATED RECOMBINANT FACTOR VIII
Gorkun O.V.	-	DO B:b INTERACTIONS HAVE A ROLE IN FIBRIN POLYMERIZATION?
Gorkun O.	-	ANALYSIS OF AFFINITY OF KNOB-HOLE INTERACTIONS RESPONSIBLE FOR FIBRIN POLYMERIZATION
Gorkun O.V.	-	FIBRINOGEN VARIANT BD432A: NEW INSIGHTS ON THE ROLE OF "B:b" INTERACTIONS IN FIBRIN POLYMERIZATION
Gorska R.	-	VITAMIN K DEFICIENCY IN PATIENTS WITH CANCER REFERRED TO A HOSPITAL PALLIATIVE CARE TEAM
Goryayev N.I.	-	CLINICAL USE OF TEST OF LYMPHOCYTE-PLATELET ADHESION
Goschnick M.W.	-	IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE
Gosselin R.C.	-	EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
	-	SUCCESSFUL ANTICOAGULATION OF INFANTS TO ADULTS WITH BIVALIRUDIN IN EXTRACORPOREAL MEMBRANOUS OXYGENATION (EMCO)
	-	EVALUATION OF A PROTOTYPE MULTIPLEX METHOD FOR EVALUATING PHOSPHOLIPID ANTIBODIES
	-	LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
	-	COMPARISON OF PRE-TEST PROBABILITY SCORES TO COMMERCIAL ASSAYS FOR MEASURING ANTIBODIES ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Gossmann J.	-	FRACTALKINE RECEPTOR CX3CR1 EXPRESSION IN PLATELETS FROM PATIENTS WITH CARDIOVASCULAR DISEASE
Goto S.	-	CONTRIBUTION OF FACTOR XA (FXA) IN THE THREE DIMENSIONAL GROWTH OF PLATELET THROMBI FORMED ON COLLAGEN FIBRILS UNDER BLOOD FLOW CONDITIONS
	-	A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
	-	DISTINCT EFFECTS OF CYCLO-OXYGENASE (COX)-1 INHIBITOR OF ASPIRIN AND P2Y12 INHIBITOR OF CLOPIDOGREL ON THE THREE DIMENSIONAL GROWTH OF ARTERIAL THROMBI FORMED AT SITE OF FUNCTIONAL DAMAGE OF ENDOTHELIAL BY FECL3
	-	RISK FACTOR PROFILE AND PATTERN OF USE OF MEDICATIONS IN JAPANESE PATIENTS AT A HIGH RISK OF CARDIOVASCULAR DIEASE: RESULTS FROM THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY AND CEREBROVASCULAR DISEASE (J-TRACE)
	-	ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS
	-	FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13
Gotoh M.	-	INCREASED LEVELS OF D-DIMER IN PATIENTS WITH MYOCARDIAL INFARCTION
	-	INCREASED THROMBIN GENERATION CAPACITY IN SEPTIC PATIENTS WITH DIC
Gottstein S.	-	LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA
	-	10-YEARS EFFICACY, SAFETY AND INHIBITORS IN ONE PLASMA-DERIVED FACTOR VIII CONCENTRATE
	-	SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION OF RECURRENT ELBOW JOINT BLEEDS IN FIVE PATIENT WITH SEVERE HAEMOPHILIA A
Gouault-Heilmann M.	-	SOURCE OF TISSUE FACTOR LEADING TO DISCREPANT PLASMA FVII LEVELS IN EIGHT FVII-DEFICIENT PATIENTS OF AFRICAN ORIGIN
Goubran H.A.	-	TRITON X-100 IS RESPONSIBLE FOR THE LOSS OF ALPHA2-ANTIPLASMIN INHIBITORY ACTIVITY IN SOLVENT-DETERGENT TREATED PLASMA
	-	EFFICACY AND SAFETY OF A NOVEL HANSENULA POLYMORPHA -DERIVED RECOMBINANT RB-VARIANT HIRUDIN FOR THROMBOPROPHYLAXIS IN ORTHOPAEDIC PATIENTS
	-	SOLUBLE P-SELECTIN RESPONSE IN PRE AND FULL-TERM NEWBORNS WITH SEPSIS
	-	THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ?
Goudemand J.	-	BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
	-	EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HAEMOPHILIA B
	-	THE VON WILLEBRAND FACTOR (VWF) AND FACTOR VIII ACTIVITIES VERSUS VWF ANTIGEN RATIOS IN PATIENTS WITH VON WILLEBRAND DISEASE TYPE 1: RESULTS FROM THE EUROPEAN MULTICENTER MCMDM-1VWD STUDY
	-	INTRA-SUBJECT VARIABILITY OF THROMBOELASTOGRAPHIC PARAMETERS FOLLOWING RFVIIA IN VIVO ADMINISTRATION IN HAEMOPHILIA PATIENTS: A MULTI-CENTRE, RANDOMIZED TRIAL
	-	FINAL ANALYSIS OF A PROSPECTIVE-MULTICENTRE STUDY TO EVALUATE EFFICACY AND SAFETY OF A TRIPLE-SECURED VON WILLEBRAND FACTOR (VWF)
	-	PLASMA-DERIVED VERSUS RECOMBINANT PRODUCTS FOR HAEMOPHILIA TREATMENT ?
	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Gouin-Thibault I.	-	SPECIFIC MULTI-RULE EXPERT SYSTEM FOR ELDERLY INPATIENT ANTICOAGULANT CONTROL
	-	OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
	-	IS MODIFICATION OF DIET IN RENAL DISEASE (MDRD) FORMULA SIMILAR TO COCKCROFT-GAULT FORMULA TO ASSESS RENAL FUNCTION IN ELDERLY HOSPITALIZED PATIENTS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)?
	-	UNFRACTIONATED HEPARIN MONITORING IN THE PRESENCE OF THE LONG-ACTING ANTI-XA AGENT IDRAPARINUX (SR34006): EFFECT OF EXOGENOUS ANTITHROMBIN
Goulder M.A.	-	TISSUE FACTOR/FACTOR VIIA INHIBITOR REDUCES ISCHEMIA IN PATIENTS WITH NSTE-ACS: FINAL RESULTS OF THE ANTHEM-TIMI 32 TRIAL
Gourdier A.	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
Gourhant L.	-	VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
Gourlin N.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Gouronnec A.	-	OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS
Gouw S.C.	-	DISCORDANT ANTIBODY RESPONSE IN MONOZYGOTIC TWINS WITH SEVERE HAEMOPHILIA A
Govan L.	-	THE INFLUENCE OF FACTOR V LEIDEN AND ABO(H) BLOOD GROUPS ON HAEMATOLOGY PARAMETERS IN EARLY PREGNANCY
	-	THE GOAL STUDY: A PROSPECTIVE EXAMINATION OF THE IMPACT OF FACTOR V LEIDEN AND ABO (H) BLOOD GROUPS ON HAEMORRHAGIC AND THROMBOTIC PREGNANCY OUTCOMES
Govers-Riemslag J.W.P.	-	MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
	-	ARGININE THERAPY TENDS TO REDUCE ENDOTHELIAL DAMAGE IN SEPSIS
Govorin A.V.	-	CHANGES IN PLATELET HAEMOSTASIS IN PATIENTS WITH ACUTE ACETIC ACID POISONING
	-	LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS
Goyal P.	-	THE PLAQUE LIPID LYSOPHOSPHATIDIC ACID STIMULATES PLATELETS NOT THROUGH THE LPA1, LPA2 AND LPA3 RECEPTOR
Goycoolea M.	-	TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
	-	PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
	-	PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
Gozdzikiewicz J.	-	WHOLE BLOOD PROCOAGULANT ACTIVITY: A POSSIBILE CELLULAR MARKER OF CARDIOVASCULAR RISK?
Grabarczyk P.	-	BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
Grabowski E.F.	-	PEDIATRIC DOSING OF AND EXPERIENCE WITH FONDAPARINUX IN DEEP VENOUS THROMBOSIS
	-	ACTIVE SITE-INHIBITED RFVIIA BLOCKS PLATELET STRING FORMATION ON INTACT ENDOTHELIUM ACTIVATED WITH TNF-ALPHA AND SHIGA TOXIN-1
Graefe-Mody E.U.	-	THE EFFECT OF BIBT 986, A NOVEL SMALL MOLECULE DUAL INHIBITOR OF THROMBIN AND FACTOR XA, ON COAGULATION IN A MODEL OF ENDOTOXIN INDUCED, TISSUE FACTOR TRIGGERED COAGULATION ACTIVATION IN HUMANS
Graeff P.A.	-	LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
Graf N.	-	HEMOPHILIA A INHIBITOR AND AUTOIMMUNNEUTROPENIA: CASE REPORT
Grafenhofer H.	-	RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
Graffigna M.	-	4G/5G POLYMORPHISM IN THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OBESE HISPANIC ADULTS
Grafos N.	-	A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
	-	CHARACTERIZATION OF ADAMTS13/FXI COMPLEX FROM PLASMA AND QUANTITATION BY ELISA IN NORMAL DONORS AND TTP PATIENTS
	-	QUANTIFICATION OF ADAMTS13 ANTIGEN, ACTIVITY AND ADAMTS13/FXI COMPLEX FROM PATIENTS WITH HEMOSTATIC/THROMBOTIC DISORDERS
Graham R.M.	-	TISSUE TRANSGLUTAMINASE DOES NOT STABILIZE ARTERIAL PLAQUES IN THE APOE DEFICIENT MOUSE
Graham G.J.	-	MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
Graham I.M.	-	HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
Grahl L.	-	PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY
Grailly S.C.	-	A LIMITED NUMBER OF ANTI-IDIOTYPIC ANTIBODIES NEUTRALIZE FVIII INHIBITORS AND RESTORE FULL FVIII ACTIVITY IN THE PLASMA OF HAEMOPHILIA PATIENTS
Grainger J.	-	AN AUDIT OF THROMBOPHILIA SCREENING IN A SINGLE PAEDIATRIC TERTIARY REFERRAL CENTRE
Gramling M.	-	ACTIVATED PROTEIN C HAS BOTH INTRACELLULAR AND EXTRACELLULAR EFFECTS ON BREAST CANCER AND ENDOTHELIAL CELL MIGRATION
Granata A.	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
Grancha S.	-	COLLAGEN AFFINITY TO VON WILLEBRAND FACTOR CONTAINED IN A THERAPEUTIC FVIII/VWF CONCENTRATE EVALUATED BY SURFACE PLASMON RESONANCE
	-	EVALUATION BY SURFACE PLASMON RESONANCE OF VWF EFFECT ON MONOCLONAL ANTIBODY DIRECTED TO FVIII LIGHT CHAIN REACTIVITY
	-	STABILITY OF HIGH PURITY THERAPEUTIC FVIII/VWF CONCENTRATE AFTER RECONSTITUTION
Grandone E.	-	A NEW MUTATION WITHIN PROTEIN Z GENE IS ASSOCIATED WITH VERY LOW PROTEIN LEVELS IN WOMEN WITH FETAL LOSS
	-	TF EXPRESSION IN HUMAN PLACENTA IS SIGNIFICANTLY ASSOCIATED WITH VEGF EXPRESSION
	-	FACTOR VIII (F8) GENE MUTATIONS AND IMMUNE TOLERANCE INDUCTION (ITI) IN HAEMOPHILIA A WITH INHIBITORS: DATA FROM THE ITALIAN ITI REGISTRY (THE PROFIT STUDY)
	-	THE RISK OF PREGNANCY-RELATED VENOUS THROMBOEMBOLISM IN DOUBLE CARRIERS OF FACTOR V LEIDEN AND PROTHROMBIN G20210A
	-	THE G20210A PROTHROMBIN VARIANT (PT-G20210A) AND THE RISK OF THROMBOEMBOLISM AND FOETAL LOSS IN PREGNANT WOMEN
	-	A RAPID METHOD FOR THE QUANTIFICATION OF THE ENANTIOMERS OF WARFARIN, PHENPROCOUMON AND ACENOCOUMAROL BY TWO DIMENSIONAL-ENANTIOSELECTIVE LIQUID CHROMATOGRAPHY/ELECTROSPRAY TANDEM MASS SPECTROMETRY
	-	EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
Grandone E.E.G.	-	A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS
Grandone E.	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
Gränitz C.	-	A NEW,BI-DIRECTIONAL POINT-OF-CARE TESTING-NETWORK FOR THE INR DETECTION FROM CAPILLARY WHOLE BLOOD WITH A POSITIVE PATIENT IDENTIFICATION IN ORALLY ANTICOAGULATED OUT-PATIENTS
Granjon S.	-	ASSESSMENT OF A METHOD BASED ON LUMINESCENCE DETECTION FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Grant P.J.	-	MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN
	-	PROTEOLYTIC CLEAVAGE OF ACTIVATED COAGULATION FACTOR XIII BY PLASMIN: NOVEL MECHANISM OF FACTOR XIII REGULATION?
Grant A.	-	EVALUATION OF THE ANTICOAGULANTS EDTA CONTAINING DISODIUM DIAZOLIDYL UREA TO PREVENT UNSOLICITED PLATELET ACTIVATION
Grant P.J.	-	COMPLEMENT C3 IS A PLASMA CLOT COMPONENT AND INFLUENCES CLOT LYSIS
	-	IDENTIFICATION OF PROTEOLYTIC CLEAVAGE
	-	PRELIMINARY RESULTS FROM EUROCLOT: HERITABILITY AND LINKAGE PEAKS FOR D-DIMER AND FIBRINOLYSIS TIME
	-	HERITABILITY OF MEASURES OF CLOT TURBIDITY AND CLOT LYSIS IN THE LEEDS FAMILY STUDY
	-	TISSUE TRANSGLUTAMINASE DOES NOT STABILIZE ARTERIAL PLAQUES IN THE APOE DEFICIENT MOUSE
	-	SECRETION OF COAGULATION FACTOR XIIIA FROM HAEMATOPOIETIC CELLS
	-	RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY
	-	THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION
Grasselli S.	-	SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION
Gratacap M.P.	-	ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION
	-	DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH
Gratacap M.	-	MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
Gratwohl A.	-	PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Grau E.	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
Gravemann U.	-	STERILIZATION OF PLATELET CONCENTRATES BY IRRADIATION WITH SHORT-WAVE ULTRAVIOLET LIGHT
Gravina M.	-	INHIBITORY EFFECT OF COFFEE ON PLATELET AGGREGATION
Gray E.	-	COMPARISON OF FIX CONCENTRATES BY CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY (CAT)
	-	OLIGOSACCHARIDES FROM DIFFERENT LOW MOLECULAR WEIGHT HEPARINS HAVE DIFFERENT ANTICOAGULANT AND PROTAMINE SULPHATE NEUTRALIZATION PROFILES
	-	THE EFFECT OF ACTIVATED FACTOR IX ON THE FACTOR IX COAGULANT AND NAPTT ACTIVITY OF A HIGH-PURITY FACTOR IX CONCENTRATE
	-	CORN TRYPSIN INHIBITOR AND THE CONTACT FACTOR PATHWAY IN THE THROMBIN GENERATION TEST (TGT)
	-	NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
Graybiel A.M.	-	CALDAG-GEFI-DEFICIENCY CAUSES IMPAIRED BETA1, BETA2, AND BETA3 INTEGRIN ACTIVATION IN NEUTROPHILS AND PLATELETS: A MODEL FOR LEUKOCYTE ADHESION DEFICIENCY-III (LAD-III)
Graziano M.	-	TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
	-	INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
Greaves M.	-	APPROACH TO THE DIAGNOSIS AND MANAGEMENT OF MILD BLEEDING DISORDERS
	-	PLATELET ACTIVATION INCREASES WITH THE SEVERITY OF PERIPHERAL ARTERIAL DISEASE: IMPLICATIONS FOR CLINICAL MANAGEMENT
	-	ARTERIAL STIFFNESS, ENDOTHELIAL FUNCTION AND THE RISK OF ISCHAEMIC STROKE
	-	PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIC EVENTS IN PATIENTS UNDERGOING MAJOR VASCULAR SURGERY
Grebe M.	-	THE DISTRIBUTION OF FACTOR SEVEN ACTIVATING PROTEASE (FSAP) IN CAROTID AND CORONARY ATHEROSCLEROTIC PLAQUES IN SUBJECTS GENOTYPED FOR THE MARBURG I POLYMORPHISM
Greber-Platzer S.	-	MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
Grebogi C.	-	CHAOTIC ADVECTION IN STENOSED ARTERIES
Greco T.P.	-	ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE?
Greco Jr T.	-	ARE ANTIPHOSPHOLIPID ANTIBODIES RISK FACTORS FOR CORONARY ARTERY DISEASE?
Green D.	-	TWO APPARENT MISSENSE MUTATIONS IN EXONS OF THE FACTOR XI GENE CAUSE SPLICING DEFECTS DISPLAYING A NOVEL MECHANISM FOR MUTATIONS IN CLOTTING FACTORS
Greenfield R.S.	-	QUANTIFICATION OF ADAMTS13 ANTIGEN, ACTIVITY AND ADAMTS13/FXI COMPLEX FROM PATIENTS WITH HEMOSTATIC/THROMBOTIC DISORDERS
	-	CHARACTERIZATION OF ADAMTS13/FXI COMPLEX FROM PLASMA AND QUANTITATION BY ELISA IN NORMAL DONORS AND TTP PATIENTS
Greenfield R.	-	A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
Greenway A.	-	MONITORING OF ORAL ANTICOAGULANT THERAPY IN CHILDREN: COMPARISON OF COAGUCHEK XS WITH VENOUS INR
	-	ENDOGENOUS THROMBIN POTENTIAL: FUNCTIONAL ROLE OF ALPHA-2-MACROGLOBULIN
Greer I.A.	-	THE GOAL STUDY: A PROSPECTIVE EXAMINATION OF THE IMPACT OF FACTOR V LEIDEN AND ABO (H) BLOOD GROUPS ON HAEMORRHAGIC AND THROMBOTIC PREGNANCY OUTCOMES
	-	THE INFLUENCE OF FACTOR V LEIDEN AND ABO(H) BLOOD GROUPS ON HAEMATOLOGY PARAMETERS IN EARLY PREGNANCY
Gregor J.	-	ACETYLSALICYLIC ACID (ASA) RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE (IHD) AS BIOINDICATOR OF THE TREATMENT STRATEGY
Gregora E.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Gregoric I.	-	PLATELET AND MONOCYTE ACTIVATION IN PATIENTS UNDERGOING CIRCULATORY SUPPORT WITH LEFT VENTRICULAR ASSIST DEVICES (LVAD)
Greinacher A.	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT): A PROSPECTIVE STUDY ON THE INCIDENCE, PLATELET-ACTIVATING CAPACITY AND CLINICAL SIGNIFICANCE OF ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODIES (ANTI-PF4/H ABS) OF THE IGG, IGM, AND IGA CLASS
	-	FACTORS INFLUENCING THE ANTI-PLATELET FACTOR 4/HEPARIN ANTIBODY (ANTI-PF4/H AB) IMMUNE RESPONSE: AN ANALYSIS OF FOUR RANDOMIZED CONTROLLED TRIALS (RCT'S) COMPARING ENOXAPARIN (ENOX) TO FONDAPARINUX (FONDA)
	-	PROTEOMICS OF CELL-BASED THERAPEUTICS - PROFILING OF ALTERATIONS IN PLATELET PROTEINS DURING STORAGE OF PLATELET CONCENTRATES
	-	HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) AND DILATED CARDIOMYOPATHY (DCM) - PARALLELS IN THE PATHOGENESIS OF TWO SEVERE IMMUNE MEDIATED CARDIOVASCULARE DISORDERS
Grenegard M.	-	REACTIVE OXYGEN SPECIES DERIVED FROM PLATELETS REDUCE THE ACTION OF NITRIC OXIDE
Grenier C.	-	CONTRIBUTION OF GENETIC ANALYSIS FOR DIAGNOSIS OF VON WILLEBRAND DISEASE TYPE 2B
Gresele P.	-	PLATELET-DERIVED NITRIC OXIDE CONTRIBUTE TO THE REGULATION OF BLOOD PRESSURE IN MICE
	-	NCX-6550, A NITRIC OXIDE-DONATING DERIVATIVE OF PRAVASTATIN, EXERTS ANTI-INFLAMMATORY ACTIVITY IN HYPERCHOLESTEROLEMIC MICE
	-	RAPID INCREASE OF EXPRESSION OF INDUCIBLE CYCLOOXYGENASE (COX-2) IN MONOCYTES OF PATIENTS WITH TYPE II DIABETES MELLITUS (T2DM) EXPOSED IN VIVO TO HYPERGLYCEMIC SPIKES
	-	BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV
	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
	-	A NEW CASE OF ACQUIRED GLANZMANN'S THROMBASTHENIA: COMPARATIVE EVALUATION OF THE DIAGNOSTIC VALUE OF DIFFERENT PLATELET FUNCTION TESTS
	-	MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
	-	LABORATORY DIAGNOSIS AND MONITORING OF DDAVP TREATMENT OF VON WILLEBRAND DISEASE BY FLOW CYTOMETRY
Gretler D.D.	-	INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR
	-	EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
Grgurevich S.	-	TYROSINE KINASE SYK PLAYS A PIVOTAL ROLE IN PLATELET SIGNALING INITIATED BY PATHOPHYSIOLOGICAL SHEAR STRESS
Griesmacher A.	-	UNEXPLAINED HIGH D-DIMER
Griesshammer M.	-	MANAGEMENT OF SEVERE PULMONARY EMBOLISM IN A PATIENT WITH HOMOZYGOUS PROTEIN C DEFICIENCY
Griffin J.H.	-	RESIDUES 311-325 ON THE HEAVY CHAIN OF FVA REPRESENT AN ACTIVATED PROTEIN C BINDING REGION
	-	GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
	-	ROLE OF PAR1 IN PROTECTIVE SIGNALING BY ACTIVATED PROTEIN C IN SYSTEMIC INFLAMMATION
	-	ACTIVATED PROTEIN C (APC) REQUIRES RESIDUES 176-178 FOR NORMAL ANTICOAGULANT, ANTI-APOPTOTIC AND ANTI-INFLAMMATORY ACTIVITIES
	-	DISSECTION OF STRUCTURAL REQUIREMENTS FOR ACTIVATED PROTEIN C ANTICOAGULANT VERSUS CYTOPROTECTIVE ACTIVITIES
	-	ACTIVATED PROTEIN C
	-	RECURRENT VENOUS THROMBOEMBOLISM LINKED TO LOW PLASMA HDL
Griffin J.	-	SENSITIVITY TO ACTIVATED PROTEIN C (APC) IS INCREASED DURING THE SECRETORY PHASE OF THE MENSTRUAL CYCLE
Griffini S.	-	HAEMOSTATIC AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS: EFFECT OF TUMOR NECROSIS FACTOR ALPHA BLOCKADE
Griffioen A.	-	THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE
	-	A MULTIDISCIPLINARY CLINIC FOR WOMEN WITH INHERITED BLEEDING DISORDERS
Griffith M.J.	-	GLYCOSYLATION OF THE ACTIVATION PEPTIDE OF FACTOR IX DETERMINES PLASMA HALF-LIFE
	-	N-GLYCAN SIALYLATION IS IMPORTANT FOR IN VIVO RECOVERY OF RECOMBINANT FACTOR IX
Griffiths A.B.M.	-	THROMBOPHILIA IN PAEDIATRIC CYSTIC FIBROSIS PATIENTS
	-	COMPARISON OF COAGUCHEK S, XS AND LABORATORY INRS
Griffiths S.	-	A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
Grifoni S.	-	HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
	-	EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Grigoriev S.V.	-	A TECHNIQUE FOR PREVENTION OF THROMBOSIS AFTER ABDOMINAL SURGERY
Grigorjeva M.E.	-	GLYCINE AND LYS-PRO-ARG-GLY: POSSIBLE MECHANISMS OF ACTION ON FIBRINOLYTIC AND ANTICOAGULANT ACTIVITY
	-	NEW VASOPRESSIN ANALOG REMESTYPE INCREASES PLASMINOGEN ACTIVATOR IN RAT BLOOD
Grimm L.	-	APPLICABILITY OF A THROMBIN GENERATION TEST IN LABORATORY SCREENING
Grindulis K.	-	CARDIOVASCULAR RISK FACTORS ARE ASSOCIATED WITH PLASMA MARKERS OF PRO-ATHEROGENIC PROCESSES IN RHEUMATOID ARTHRITIS
Grinenko T.V.	-	INFLUENCE OF THE STREPTOKINASE 36 KDA FRAGMENT ON THE PLASMIN ACTIVITY
Gringeri A.	-	PREFERENCES TOWARDS COAGULATION FACTOR CONCENTRATES USED TO TREAT HEMOPHILIC PATIENTS WITH INHIBITORS: THE PATIENTS', PHYSICIANS' AND PHARMACISTS' PERSPECTIVE
	-	THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES
Gris J.C.	-	SIMPLE COAGULATION TESTS IMPROVE EARLY MORTALITY PREDICTION IN ICU PATIENTS WITH SEPTIC SHOCK
	-	THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
	-	ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
Gris J.	-	CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Gris J.C.	-	PROSPECTIVE EVALUATION OF A SIMPLIFIED SCORE FOR THE PREDICTION OF DISSEMINATED INTRAVASCULAR COAGULATION IN SEPSIS
Grisaru D.	-	ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
Gritsch H.	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
	-	PRIMARY HEMOSTATIC EFFICACY OF RVWF IN A NOVEL MODEL OF VASCULAR INJURY IN MICE WITH SEVERE VWF DEFICIENCY
	-	BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
	-	PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD
Gritsenko P.G.	-	A FIBRIN-SPECIFIC MONOCLONAL ANTIBODY WITH EPITOPE LOCALIZED IN FIBRIN FRAGMENT BBETA118-134: ITS APPLICATION TO QUANTIFICATION OF SOLUBLE FIBRIN
Groeneveld Y.	-	HIGH LEVELS OF LDL-CHOLESTEROL AND TRIGLYCERIDES AND SUBOPTIMAL GLYCEMIC CONTROL PREDICT DIMINISHED EX VIVO ASPIRIN RESPONSIVENESS IN PATIENTS WITH TYPE 2 DIABETES
Gromellon N.	-	MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
Gröner A.	-	AN INTEGRATED APPROACH TO EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED VWF/FVIII CONCENTRATE
	-	EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED PROTHROMBIN COMPLEX CONCENTRATE THROUGH MULTIPLE DEDICATED MEASURES
	-	ADDITION OF PRION REDUCTION FACTORS FROM SINGLE STEP EXPERIMENTS MAY OVERESTIMATE MANUFACTURING PROCESS CLEARANCE CAPABILITY
Gröning A.	-	CLINICAL EXPERIANCE WITH A RAPID SCREENING TEST FOR HEPARIN/PF4-ANTIBODIES
Groot E.	-	THE IMPORTANCE OF DETECTING ANTI-ADAMTS-13 ANTIBODIES IN PATIENTS WITH SEVERE ADAMTS-13 DEFICIENCY
Groot A.P.	-	INHIBITION OF PROTEASE-ACTIVATED RECEPTOR (PAR)-4 PROTECTS FROM MULTI-ORGAN FAILURE IN A MURINE MODEL OF DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
	-	GENE EXPRESSION PROFILING IDENTIFIES C/EBP-DELTA AS A CANDIDATE REGULATOR OF ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION (DIC)
Groot E.	-	GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
	-	ACTIVE CONFORMATION OF VON WILLEBRAND FACTOR IN TTP IS NOT RESTRICTED TO ULTRA-LARGE MULTIMERS
	-	THE EFFECT OF EXERCISE ON INDIVIDUALS WITH TYPE 1 AND TYPE 2B VON WILLEBRAND DISEASE (VWD)
Gros P.	-	ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS
Gross P.	-	ROLE OF PLASMA FIBRONECTIN IN FIBRINOGEN/VWF-INDEPENDENT THROMBUS FORMATION
Gross P.L.	-	HEMOSTASIS IN FACTOR VIII DEFICIENT MICE IS IMPROVED AFTER THE INFUSION OF MONOCYTE-DERIVED MICROPARTICLES
Grosse J.	-	AN EF-HAND MUTATION IN STIM1 CAUSES PREMATURE PLATELET ACTIVATION AND BLEEDING IN MICE
Grosser M.	-	CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
Grossi C.	-	EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
	-	DETECTION OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES: THE INFLUENCE OF DIFFERENT ANTIGEN PREPARATIONS
	-	ANTIPHOSPHOLIPID ANTIBODIES AND EX-VIVO ENDOTHELIAL PERTURBATION
Grossin N.	-	MESOTHELIAL RAGE ACTIVATION BY AGES ENHANCES VEGF RELEASE AND POTENTIATES CAPILLARY TUBE FORMATION
Grossmann R.	-	ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
Großmann R.	-	INFLUENCE OF ANTIEPILEPTIC DRUGS ON THE COAGULATION
	-	PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE
Grossmann R.	-	PLATELET PROINFLAMMATORY AND HEMOSTATIC FUNCTIONS IN PATIENTS WITH CYSTIC FIBROSIS
	-	THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS
	-	PLATELET-LEUKOCYTE INTERACTION: A CLEAR AGE DEPENDENCY
Grosso S.H.	-	FACTOR XIII DEFICIENCY: SYMPTOMS, DIAGNOSIS AND LONG-TERM REPLACEMENT THERAPY
Grosso S.	-	HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY
	-	AN ASSOCIATION OF VICENZA AND NORMANDY VARIANTS VON WILLEBRAND DISEASE (VWD)
Grosso S.H.	-	DIAGNOSIS AND FOLLOW UP OF FACTOR XIII DEFICIENCY: COMPARISON OF DIFFERENT CLOT-SOLUBILITY TESTS
Grosso S.	-	IS THERE ANY CORRELATION BETWEEN FIBRINOLYTIC ACTIVITY AND BLEEDING SCORE IN TYPE 1 AND POSSIBLE TYPE 1 VON WILLEBRAND DISEASE?
Grosso S.H.	-	ANTITHROMBIN (AT): A CONFORMATIONAL VARIANT?
Grosso S.	-	POISONING WITH SUPERWARFARIN
Groth A.V.	-	IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
	-	EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
Grounds M.	-	EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII (NOVOSEVEN) IN TRAUMA AND SURGERY PATIENTS WITH MASSIVE BLEEDING A REGISTER ANALYSIS
Gruber A.	-	GLYCOPROTEIN Ib MEDIATES PLATELET RECRUITMENT, ACTIVATION AND AGGREGATION ON IMMOBILIZED PROTEIN C AND ACTIVATED PROTEIN C UNDER SHEAR
Gruber P.	-	LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
Gruber A.	-	REDUCED MORTALITY OF PERITONEAL SEPSIS IN FACTOR XI DEFICIENT MICE
	-	PROTEIN C ACTIVATOR (PCA) TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME OF EXPERIMENTAL THROMBOTIC ISCHEMIC STROKE IN MICE
	-	IN VIVO ANTITHROMBOTIC ACTIVITY OF PROTEIN S (PS) THAT IS INDEPENDENT OF APC
	-	FACTOR XI MEDIATES PLATELET LAMELLIPODIA FORMATION AND TETHERING AND ROLLING UNDER SHEAR CONDITIONS
Gruber G.	-	PRODUCT FEATURES OF THE NOVEL GENERATION VWF/FVIII CONCENTRATE IN A COMPARISON WITH FIRST GENERATION PRODUCTS
Gruber A.	-	HIGH SENSITIVITY THROMBOGENIC MARKER DETECTION IN THE INTRALUMINAL BOUNDARY LAYER
	-	THE THROMBIN MUTANT W215A/E217A ACTS AS A PLATELET ANTAGONIST THROUGH INHIBITION OF THROMBIN ACTIVATION AND GPIB BINDING TO VWF
Gruber F.	-	PRIMARY HUMAN SYNOVIAL CELLS PROLIFERATE IN RESPONSE TO HEMOGLOBIN AND WHOLE BLOOD
Gruber G.	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
Gruber R.	-	EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
Gruber G.	-	VWF:RCO ASSAYS USING AUTOMATED SYSTEMS FOR VWF/FVIII CONCENTRATES REQUIRE ADJUSTMENT OF ASSAY REAGENTS, COMPOSITION AND PERFORMANCE PARAMETERS
Gruber A.	-	PROTEIN C ACTIVATOR (PCA) INTERRUPTION OF THROMBUS PROPAGATION WITHOUT ANTIHEMOSTATIC SIDE EFFECT IN PRIMATES
Gruber G.	-	PRION PROTEIN REMOVAL DURING MANUFACTURING OF HIGH-PURITY VWF/FVIII CONCENTRATES
Gruda M.	-	EFFECT OF RECOMBINANT FACTOR XIII-A ON ENDOTHELIAL BARRIER FUNCTION
Gruel Y.	-	A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I
	-	INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
	-	IS THE RISK OF VENOUS THROMBOEMBOLISM HIGHER WITH CYPROTERONE CONTRACEPTIVES?
	-	ASSOCIATION BETWEEN THE HOMOZYGOUS STATUS FOR THE 807T ALLELE OF ITGA2 AND RETINAL ARTERY OCCLUSION
	-	PERFORMANCES OF A NEW ELISA (ZYMUTEST HIA) FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA
Gruman Z.	-	OPTIMIZATION OF COAGULATION FACTOR ASSAYS FOR IMPROVED ACCURACY OVER AN EXTENDED LINEAR RANGE
Grundt H.	-	ACTIVATED FACTOR XII TYPE A INDEPENDENTLY PREDICTS 12 MONTH MORTALITY IN CHEST PAIN PATIENTS
	-	NT-PROBNP, AND NOT TF, FM, PAPP-A, MPO OR CD40 LIGAND, PREDICTS RECURRENT TROPONIN-T POSITIVE CARDIAC EVENTS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION
Grundvold I.	-	PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION
Gruppo R.A.	-	INCREASED AGE RELATED EXPRESSION OF FVIII IN TWO UNRELATED FEMALES WITH SEVERE HEMOPHILIA A AND NONRANDOM X-INACTIVATION
	-	THROMBOPHILIC POLYMORPHISMS IN PEDIATRIC CATHETER RELATED VERSUS NON CATHETER RELATED VENOUS THROMBOEMBOLISM
	-	HETEROZYGOUS FIBRINOGEN GAMMA-375 ARG-TRP MUTATION ASSOCIATED WITH EXCESSIVE SIALYLATION, PLASMIN RESISTANCE AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Gruz F.	-	FACTOR V IS AN INDEPENDENT PREDICTOR OF MORTALITY IN PATIENTS WITH CIRRHOSIS: USEFUL TOOL IN PATIENTS WAITING FOR LIVER TRANSPLANTATION
Grzanka P.	-	IMPROVEMENT OF THIOLACTONASE ACTIVITY OF PARAOXONASE 1 BY SIMVASTATIN IN PATIENTS WITH CORONARY ARTERY DISEASE
Gu J.	-	OVEREXPRESSION OF INFLAMMATORY FACTORS ASSOCIATED WITH PROTHROMBOTIC STATE IN LEUKEMIA PATIENTS
Gu C.	-	THE RISK OF FATAL PULMONARY EMBOLISM AFTER STOPPING ANTICOAGULANT THERAPY IN PATIENTS WITH VENOUS THROMBOEMBOLISM
Gu J.	-	ALTERATIONS OF INFLAMMATORY AND HAEMOSTATIC INDICES IN RHEUMATIC DISEASES
Gu C.	-	EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
Gu D.	-	SERUM BAFF LEVELS IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
Guadagni F.	-	RELATIONSHIP BETWEEN INFLAMMATORY INDEXES ON ADMISSION AND DIAGNOSIS OF ACUTE AORTIC DISSECTION
	-	OBSERVATIONAL STUDY OF 150 WOMEN WITH INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
	-	ASSOCIATION BETWEEN ENHANCED VEGF LEVELS AND PLATELET ACTIVATION IN HYPERTENSIVE PATIENTS
Guadagnin M.L.	-	INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY
Guagnano M.	-	ASSOCIATION BETWEEN ENHANCED SOLUBLE CD40 LIGAND AND PLATELET ACTIVATION IN HYPERTENSIVES WITH MICROALBUMINURIA
Guang I.	-	KNOCKOUT OF THE THROMBOXANE SYNTHASE CAUSES REDUCTION OF VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND MIGRATION IN AN ARTERY INJURY MODEL
Guardascione M.A.	-	COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS
Guardigli G.	-	FACTOR XIIIA-V34L AND FACTOR XIIIB-H95R GENE VARIANTS AND SURVIVAL AFTER MYOCARDIAL INFARCTION
Guarini P.	-	INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Guazzaloca G.	-	THE ROLE OF D-DIMER AS A RISK FACTOR FOR OCCULT CANCER AND CARDIOVASCULAR EVENTS AFTER ANTICOAGULATION WITHDRAWAL FOR A FIRST IDIOPATHIC DEEP VEIN THROMBOSIS IN THE PROLONG STUDY
Gudmundsdottir B.R.	-	PREDICTION OF PRIMARY HEMOSTATIC DEFECT TYPE AND SEVERITY WITH THE PFA-100 CLOSURE TIME
	-	WARFARIN ANTICOAGULATION INTENSITY IN SPECIALIST-BASED AND IN COMPUTER -ASSISTED DOSING PRACTICE
Guedes M.	-	MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
Guella I.	-	CHARACTERIZATION OF THE F11 ALTERNATIVE SPLICING PATTERN: IDENTIFICATION OF A NOVEL COAGULATION FXI ISOFORM
Guenther N.	-	ANALYSIS OF THE INTERACTOME IN HUMAN PLATELETS
Guérois C.	-	FACTOR V LEIDEN MUTATION AND TROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) POLYMORPHISMS ARE MILD GENETIC MODIFIERS OF HEMORRHAGIC PHENOTYPE IN HEMOPHILIA
Guerois C.	-	INFLUENCE OF THE SOURCE OF PHOSPHOLIPIDS FOR APTT-BASED FIX ASSAYS AND POTENTIAL CONSEQUENCES FOR THE DIAGNOSIS OF MILD/MODERATE HAEMOPHILIA B
Guerrero F.	-	ESTIMATING THE INFLUENCE OF MEASUREMENT VARIABILITY ON DIAGNOSTIC ERRORS: A BAYESIAN MODEL APPLIED TO QUANTITATIVE D DIMER ASSAYS FOR THE EXCLUSION OF VENOUS THROMBOSIS
	-	COMPONENTS OF VARIABILITY OF D DIMER MEASUREMENT CLOSE TO THE CUT-OFF VALUE
	-	AUTOMATED QUANTIFICATION OF VON WILLEBRAND FACTOR ACTIVITY WITH HEMOSIL ON THE CA 7000 COAGULOMETER: A VALIDATION STUDY
Guerriero R.	-	EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
Guevara L.	-	MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Guglielmini G.	-	NCX-6550, A NITRIC OXIDE-DONATING DERIVATIVE OF PRAVASTATIN, EXERTS ANTI-INFLAMMATORY ACTIVITY IN HYPERCHOLESTEROLEMIC MICE
	-	A NEW CASE OF ACQUIRED GLANZMANN'S THROMBASTHENIA: COMPARATIVE EVALUATION OF THE DIAGNOSTIC VALUE OF DIFFERENT PLATELET FUNCTION TESTS
	-	PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME PRESENT A NORMAL ENDOTHELIAL FUNCTION
Guglielmone H.	-	PAI-1 GENE 4G/5G GENOTYPE AS AN ADDITIONAL RISK FACTOR IN PATIENTS WITH THROMBOSIS: A RETROSPECTIVE COHORT STUDY
	-	COMPARATIVE "IN VITRO" CHARACTERIZATION OF DIFFERENT PROTHROMBIN COMPLEX CONCENTRATES
	-	ANTICOAGULATION IN A PATIENT WITH SEVERE PREECLAMPSIA, POSITIVE ANTIBETA2-GLYCOPROTEIN I ANTIBODIES AND HOMOZIGOSITY FOR PAI-1 AND MTHFR
Gugliotta L.	-	PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
	-	A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT
Guicheteau M.	-	IDENTIFICATION AND EXPRESSION OF R763G MUTATION ABOLISHING THE CLEAVAGE OF VON WILLEBRAND FACTOR PROPEPTIDE, AT THE HETEROZYGOUS AND HOMOZYGOUS STATE
Guida A.	-	PREDISPOSING FACTORS IN PATIENTS WITH EARLY-ONSET CEREBRAL VEIN THROMBOSIS
	-	RIGHT-TO-LEFT SHUNT, ATRIAL SEPTAL ANEURYSM AND THROMBOPHILIA IN PATIENTS WITH CRYPTOGENIC STROKE OR TIA VERSUS THOSE WITH VENOUS THROMBOEMBOLISM
Guiet P.	-	FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM
Guillaumon A.T.	-	DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA
Guillemette P.	-	USEFULNESS OF MULTIDETECTOR COMPUTED TOMOGRAPHY IN PATIENTS WITH SYMPTOMS SUGGESTING PULMONARY EMBOLISM
Guilliatt A.M.	-	A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES
Guilliatt A.	-	RATE OF DE NOVO VWF MUTATIONS IN PATIENTS HISTORICALLY DIAGNOSED WITH TYPE 1 VWD IN THE EUROPEAN STUDY, MOLECULAR AND CLINICAL MARKERS FOR THE DIAGNOSIS AND MANAGEMENT OF TYPE 1 VWD (MCMDM-1VWD)
Guilliatt A.M.	-	HETEROGENEOUS SEQUENCE CHANGES IN THE PROMOTER AND CODING SEQUENCE OF THE FACTOR VIII GENE IDENTIFIED IN 247 FAMILIES FROM THE UK
	-	A MUTATION IN EXON 27 OF THE VWF GENE CAUSING TYPE 2M AND TYPE 3 VON WILLEBRAND DISEASE IN THREE PATIENTS IN A FAMILY FROM THE WEST OF SCOTLAND
Guillin M.	-	SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS
	-	A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE?
Guillin M.C.	-	MECHANISMS ASSOCIATED WITH FAILURE OF THROMBOLYTIC THERAPY TO RECANALIZE THE INFARCT ARTERY IN ACUTE MYOCARDIAL INFARCTION
Guillot N.	-	THE EFFECTS OF DOCOSAHEXAENOIC ACID IN PLATELETS (AN EX VIVO STUDY) AND IN MEGAKARYOCYTIC CELLS (AN IN VITRO STUDY)
Guinet C.	-	THREE DIFFERENT PATTERNS OF CALIBRATED AUTOMATED THROMBOGRAM OBTAINED WITH HIRUDIN, MELAGATRAN, DABIGATRAN, ARGATROBAN, FONDAPARINUX AND DANAPAROD
Guinto E.	-	QUANTIFICATION OF ADAMTS13 ANTIGEN, ACTIVITY AND ADAMTS13/FXI COMPLEX FROM PATIENTS WITH HEMOSTATIC/THROMBOTIC DISORDERS
	-	CHARACTERIZATION OF ADAMTS13/FXI COMPLEX FROM PLASMA AND QUANTITATION BY ELISA IN NORMAL DONORS AND TTP PATIENTS
	-	A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
Guizzardi G.	-	DETERMINANTS OF PLATELET ACTIVATION IN HEART FAILURE
Gujanica Z.	-	RISK FACTORS FOR THROMBOSIS IN CHILDREN
Gulacsi-Bardos P.	-	CLOPIDOGREL TREATMENT SIGNIFICANTLY DECREASES CIRCULATING ENDOTHELIAL CELL COUNT IN PATIENTS WITH STABLE ANGINA
Gulin D.A.	-	INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS
	-	FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA
Gummert J.	-	EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
	-	THE VALUE OF ROTEM THROMBOLELASTOMETRY TO DETECT DISTURBED HAEMOSTASIS AND BLEEDING RISK IN ON-PUMP CARDIAC SURGERY
Gumruk F.	-	RISK FACTORS AND OUTCOME OF PEDIATRIC THROMBOTIC EPISODES IN A SINGLE CENTER
Gumulec J.	-	LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
Guner G.	-	ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS
Guo Y.	-	MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
Guo C.S.	-	CORRECTION OF TH1 DOMINANT CYTOKINE PROFILES BY HIGH DOSE DEXAMETHASONE IN PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA
Guo Y.	-	FIBRIN A-ALPHA PEPTIDE MEDIATED DELIVERY OF BIOLOGICALLY ACTIVE PROTEINS
Gupta S.	-	A FLUOROGENIC THROMBIN GENERATION TEST (FTGT) FOR FACTOR VIII ACTIVITY DEMONSTRATED SUCCESS OF CELL THERAPY WITH LIVER SINUSOIDAL ENDOTHELIAL CELLS (LSEC) IN HAEMOPHILIA A MICE
Gurbel P.A.	-	VULNERABLE BLOOD MEASURED BY THROMBELASTOGRAPHY: A PREDICTOR OF TARGET LESION REVASCULARIZATION AFTER CORONARY STENTING
	-	DO WE COMPLETELY UNDERSTAND THE ANTITHROMBOTIC EFFECT OF ASPIRIN?
	-	IS THE ASSESSMENT OF CLOPIDOGREL RESPONSIVENESS AFFECTED BY THE ANTICOAGULANT OR MEASUREMENT OF MAXIMUM PLATELET AGGREGATION OR FINAL PLATELET AGGREGATION?
	-	SYNERGISTIC EFFECT OF SMOKING ON PLATELET RESPONSIVENESS TO CLOPIDOGREL
	-	EFFECTS OF DIABETES ON THE PREVALENCE OF ASPIRIN RESISTANCE DURING LOW DOSE ASPIRIN THERAPY
	-	POST - CORONARY INTERVENTION RECURRENT ISCHEMIA IN THE PRESENCE OF ADEQUATE PLATELET INHIBITION BY DUAL ANTIPLATELET THERAPY: WHAT ARE WE OVERLOOKING?
	-	BIOMARKER ANALYSIS BY FLUOROKINE MULTI-ANALYTE PROFILING DISTINGUISHES PATIENTS REQUIRING INTERVENTION FROM PATIENTS WITH LONG-TERM QUIESCENT CORONARY ARTERY DISEASE: A POTENTIAL APPROACH TO IDENTIFY ATHEROSCLEROTIC DISEASE PROGRESSION
	-	RELATION OF PLATELET-FIBRIN CLOT STRENGTH, PLATELET REACTIVITY, INFLAMMATION AND GROWTH FACTOR RELEASE TO THROMBOTIC RISK IN PATIENTS UNDERGOING STENTING
	-	THE RELATION OF HIGH EX VIVO THROMBOGENIC POTENTIAL TO HIGH ISCHEMIC RISK IN AFRICAN AMERICAN WOMEN UNDERGOING CORONARY STENTING
	-	SUPERIOR EFFECT OF EPTIFIBATIDE ADDED TO CLOPIDOGREL ON BIOMARKER EXPRESSION DETECTED BY FLUOROKINE MULTI-ANALYTE PROFILING IN PATIENTS UNDERGOING ELECTIVE PCI
	-	EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
	-	TRANSITION TO AN UNSTABLE CORONARY SYNDROME IS MARKED BY HYPERCOAGUABILITY, PLATELET ACTIVATION, HEIGHTENED PLATELET REACTIVITY, AND INFLAMMATION: RESULTS OF THE THROMBOTIC RISK PROGRESSION (TRIP) STUDY
	-	MYONECROSIS IS PREDICTED BY HIGH REACTIVITY TO MULTIPLE PLATELET AGONISTS: A TRANSLATIONAL STUDY OF PATIENTS UNDERGOING STENTING TREATED WITH BIVALIRUDIN AND HIGH DOSE CLOPIDOGREL
	-	INHIBITION OF PLATELET AGGREGATION: A NOVEL EFFECT OF C-REACTIVE PROTEIN
	-	PLATELET FUNCTION MEASURED BY VERIFYNOW IDENTIFIES GENERALIZED HIGH PLATELET REACTIVITY IN ASPIRIN TREATED PATIENTS
	-	PATIENTS WITH METABOLIC SYNDROME DEMONSTRATE HIGH PLATELET REACTIVITY AND INCREASED PROCOAGULANT MARKERS
	-	LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
Gurgey A.	-	RISK FACTORS AND OUTCOME OF PEDIATRIC THROMBOTIC EPISODES IN A SINGLE CENTER
Gurgoze M.	-	USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY
Gurlich R.	-	MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
Gurney M.	-	PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931
Gurney D.A.	-	PLATELET GLYCOPROTEINS: PREDICTORS OR PROGRESSION MARKERS IN CARDIOVASCULAR DISEASE?
Gurney M.	-	EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
Gurniak C.	-	COFILIN, BUT NOT ADF, IS ESSENTIAL IN PLATELET FORMATION IN VIVO
Gursel T.	-	LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Gusina A.A.	-	HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOSIS IN BELARUS
Gusina N.B.	-	HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOSIS IN BELARUS
Gusnanto A.	-	MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
	-	DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
Gustafsson K.M.	-	THE PLASMA SAMPLE DILUTION IMPROVES THE CORRELATION BETWEEN REAGENTS FOR PT-METHODS
Güthner C.	-	DISTINCTIVE THROMBOELASTOGRAPHIC FINDINGS (TEG-PM IN RESPONSE TO ADP) IN A FAMILY WITH BERNARD SOULIER SYNDROME
Guthold M.	-	THE VISCOELASTIC PROPERTIES OF SINGLE, CROSSLINKED AND UNCROSSLINKED FIBRIN FIBERS
Gutierrez M.	-	PROGNOSTIC FACTORS OF SHORT-TERM SURVIVAL IN PATIENTS WITH DEEP VEIN THROMBOSIS: FINDINGS FROM A PROSPECTIVE REGISTRY (RIETE)
	-	D-DIMER LEVELS CORRELATE WITH MORTALITY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: FINDINGS FROM THE RIETE REGISTRY
Gutierrez-Pimentel J.M.	-	CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Guven M.	-	DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY
Guven G.S.	-	DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY
Guyatt G.	-	DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY
Guyetand C.	-	BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
Guyomarc'h S.	-	EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
Guzman A.	-	TREATMENT WITH RECOMBINANT ACTIVATED FVII DECREASES FVIII INHIBITOR TITLE
	-	COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN
Gwozdz A.M.	-	INHIBITION OF AMINOPHOSPHOLIPID TRANSLOCASE ACTIVITY IN PHOSPHATIDYLSERINE-EXPOSING HUMAN PLATELETS IS INDEPENDENT OF CALPAIN ACTIVITY
Gyrgy A.A.	-	INFLUENCE OF HYPERHOMOCYSTEINEMIA ON THE ACTIVITY OF CATALASE
Gyzander E.	-	ENZYME KINETIC CHARACTERISATION OF THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837